COVID-19 Evidence Reviews
as of 5/24/22
menu
 
 

Clinical Characteristics
 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
5/24/22
Ulloque-Badaracco JR, Mosquera-Rojas MD, Hernandez-Bustamante EA, et al. | Heliyon
Aim: To evaluate the prognostic value of the AGR in COVID-19 patients.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/17/22
Alshammary AF, Alsughayyir JM, Alharbi KK, et al. | Front Med
Aim: To analyze T-cell subsets (CD4/CD8) and IL-10 in severe and fatal cases of COVID-19.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Vaseghi N, Sharifisooraki J, Khodadadi H, et al.  | Mycoses
Aim: To evaluate and estimate the global prevalence of coronavirus-associated C. auris infection (CACa).
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Ruvinsky S, Voto C, Roel M, et al. | Front Pediatr
Aim: To describe the clinical course, laboratory findings, epidemiology, treatment, and use of resources of MIS-C in children from LAC.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/16/22
Santana LADM, Vieira WA, Gonçalo RIC, et al. | J Stomatol Oral Maxillofac Surg
Aim: To better understand the relationship between COVID-19 infection and oral lesions.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/12/22
Tavares-Júnior JWL, de Souza ACC, Borges JWP, et al. | Cortex
Aim: To determine any relationship between COVID-19 and cognitive complaints, such as dementia, mild cognitive impairment (MCI), or subjective cognitive decline (SCD).
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
5/11/22
Chang Y, Bai M, You Q | Biomed Res Int
Aim: To investigate the association between interleukins (IL-1beta, IL-2, IL-4, IL-6, IL-8, and IL-10) and the disease severity of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/11/22
Jiang L, Tang K, Irfan O, et al. | Curr Pediatr Rep
Aim: To investigate and synthesize evolving evidence on its clinical characteristics, management, and outcomes in pediatric patients.
CLINICAL CHARACTERISTICS
5/10/22
Weng Y, Yi GY | J Med Virol
Aim: To provide sensible estimates of the mean incubation time of COVID-19 by capitalizing on available estimates reported in the literature and exploring different ways to accommodate heterogeneity involved in the reported studies.
CLINICAL CHARACTERISTICS
5/2/22
Doceda MV, Gavriiloglou M, Petit C, et al. | Oral Health Prev Dent
Aim: To evaluate the potential association of COVID-19 infection with oral health.
CLINICAL CHARACTERISTICS
5/2/22
Shahsavarinia K, Rahvar G, Soleimanpour H, et al. | Pak J Med Sci
Aim: To investigate the underlying factors causing pneumothorax, pneumomediastinum, and subcutaneous emphysema in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/2/22
Gupta S, Jawanda MK | Eur J Neurol
Aim: To evaluate the number of published cases of Bell's palsy as the only major neurological manifestation in patients with COVID-19 from March 2020 to December 2021 and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
5/2/22
Kow CS, Ramachandram DS, Hasan SS | J Cardiovasc Pharmacol
Aim: To perform a systematic review and meta-analysis to determine the effect of preadmission/prediagnosis use of CCBs on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/22
Alosaimi B, AlFayyad I, Alshuaibi S, et al. | BMC Sports Sci Med Rehabil
Aim: To measure the prevalence of CV complications suffered by COVID-19 athletic patients, explore the outcomes, optimal approaches to diagnoses, and safe return-to-play considerations.
CLINICAL CHARACTERISTICS
4/26/22
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
4/22/22
Giannos P, Katsikas Triantafyllidis K, et al. | Front Neurol
Aim: To screen the current literature and provide a summary of the reported cases of SARS-CoV-2 infected patients presenting with persistent hiccups.
CLINICAL CHARACTERISTICS
4/21/22
Kastora S, Patel M, Carter B, et al. | Endocrinol Diabetes Metab
Aim: To analyse the collective and geographically stratified mortality, ICU admission, ventilation requirement, illness severity and discharge rate amongst patients with diabetes.
UPDATED
CLINICAL CHARACTERISTICS
4/19/22
Chen C, Haupert SR, Zimmermann L, et al. | J Infect Dis
Aim: To examine the worldwide prevalence of post COVID-19 condition.
CLINICAL CHARACTERISTICS
4/19/22
Alahyari S, Rajaeinejad M, Jalaeikhoo H, et al. | Arch Iran Med
Aim: To evaluate the role of regulatory T cells (Tregs) as one of the main cells that maintain immune homeostasis.
CLINICAL CHARACTERISTICS
4/18/22
Sabaghian T, Rommasi F, Omidi F, et al. | Bratisl Lek Listy
Aim: To collate the condition and risk factors of AKI and non-AKI COVID-19 patients and to investigate AKI incidence in high-risk patients.
CLINICAL CHARACTERISTICS
4/14/22
Daniels NF, Burrin C, Chan T, et al. | Curr Dev Nutr
Aim: To explore the indirect effects of the first year of COVID-19 on obesity and its risk factors.
UPDATED
CLINICAL CHARACTERISTICS
4/14/22
Rahmati M, Shamsi MM, Khoramipour K, et al. | Rev Med Virol
Aim: To explore the hospitalisation, intensive care unit (ICU) admissions, and mortality rates of COVID-19 patients with a history of PA participation before the onset of the pandemic, and to evaluate the reliability of the evidence.
CLINICAL CHARACTERISTICS
4/14/22
Yang H, Rigsby M, Zhu X, et al. | HERD
Aim: To identify factors associated with LTCF residents' COVID-19 infections and the impacts of the pandemic and the corresponding preventive measures on residents' mental health and behavioral problems.
CLINICAL CHARACTERISTICS
4/14/22
Umbrello M, Venco R, Antonucci E, et al. | Minerva Anestesiol
Aim: To investigate the incidence, risk factors and clinical outcomes of barotrauma among critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
4/14/22
Modica G, Bianco M, Sollazzo F, et al. | Int J Environ Res Public Health
Aim: To assess the event rates of myocarditis detected by Cardiac Magnetic Resonance (CMR) in athletes who recovered from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/11/22
Koupaei M, Mohamadi MH, Yashmi I, et al. | J Clin Lab Anal
Aim: To evaluate the features of COVID-19 relapse patients.
CLINICAL CHARACTERISTICS
4/11/22
Huang D, Zunong J, Li M, et al. | Curr HIV/AIDS Rep
Aim: To review the evidence on the epidemiological characteristics and clinical presentation of coinfected patients in China, as well as laboratory indicators, antiretroviral therapy status, and disease outcomes in PLHIV coinfected with CoV.
CLINICAL CHARACTERISTICS
4/11/22
Boden I, Bernabeu MO, Dhillon B, et al. | Diabetes Res Clin Pract
Aim: To test the hypothesis that pre-existing diabetic retinopathy (DR), a microvascular disease, is a prognostic indicator for poor COVID-19 outcome in this heterogeneous population.
CLINICAL CHARACTERISTICS
4/11/22
Chaudhry ZS, Nellessen N, Reis C, et al. | Fam Pract
Aim: To identify and summarize clinical reports of acute inflammatory arthritis associated with COVID-19.
CLINICAL CHARACTERISTICS
4/7/22
Hopefl R, Ben-Eltriki M, Deb S | J Pharm Pharm Sci
Aim: To analyze the association of vitamin D levels with the inflammatory markers in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/7/22
Naimi A, Yashmi I, Jebeleh R, et al. | J Clin Lab Anal
Aim: To review the literature reporting the COVID-19 outcomes in patients with hematological malignancies.
CLINICAL CHARACTERISTICS
4/7/22
Fu XL, Qian Y, Jin XH, et al. | Lupus
Aim: To evaluate the epidemiology of SLE and COVID-19, to identify the clinical characteristics of SLE patients with COVID-19, to clarify the treatment of COVID-19 in SLE patients and to assess the impact of COVID-19 pandemic on SLE patients.
CLINICAL CHARACTERISTICS
4/7/22
Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, et al.  | J Clin Lab Anal
Aim: To evaluate the prevalence of neurological complications arises from SARS-CoV-2 and assess the mortality rate from neurological complications.
CLINICAL CHARACTERISTICS
4/6/22
Gupta AK, Leslie A, Hewitt JN, et al. | ANZ J Surg
Aim: To characterize outcomes of COVID-19 positive patients undergoing cardiac surgery.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Liu M, Mei K, Tan Z, et al.  | Can J Gastroenterol Hepatol
Aim: To evaluate the relationship between liver fibrosis scores and adverse outcomes in patients with COVID-19, as well as potential dose-response association.
UPDATED
CLINICAL CHARACTERISTICS
4/6/22
Calvert C, John J, Nzvere FP, et al. | Glob Health Action
Aim: To report the findings of a rapid systematic review of studies on levels of maternal mortality before and during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
4/4/22
Patanavanich R, Siripoon T, Amponnavarat S, et al. | Nicotine Tob Res
Aim: To explore the association between current smoking and the risk for mortality due to COVID-19.
CLINICAL CHARACTERISTICS
4/4/22
Wang Y, Kang L, Chien CW, et al. | Front Cardiovasc Med
Aim: To compare the characteristics, management, and clinical outcomes between the COVID-19 and non-COVID-19 patients concomitant STEMI.
UPDATED
CLINICAL CHARACTERISTICS
4/4/22
Len P, Iskakova G, Sautbayeva Z, et al. | Front Cardiovasc Med
Aim: To assess the association between early hemostatic parameters and infection severity.
CLINICAL CHARACTERISTICS
4/4/22
Yang F, Xu Y, Dong Y, et al. | Pancreatology
Aim: To determine the pooled prevalence and prognostic significance of increased pancreatic enzymes in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
4/1/22
Khedr A, Al Hennawi H, Rauf I, et al. | Infez Med
Aim: To assess and compare mortality outcomes between LMICs and high-income countries (HICs).
CLINICAL CHARACTERISTICS
4/1/22
El-Qushayri AE, Mahmoud MA, Salman S, et al. | Dermatol Ther
Aim: To evaluate the safety of dupilumab use in the management of atopic dermatitis (AD) during the current pandemic regarding the risk and the hazards of COVID-19 infection.
CLINICAL CHARACTERISTICS
4/1/22
Wang F, Ma Y, Xu S, et al. | Clin Rheumatol
Aim: To assess the risk of COVID-19 in patients with rheumatic diseases.
CLINICAL CHARACTERISTICS
4/1/22
Figueiredo EAB, Silva WT, Tsopanoglou SP, et al. | Rev Soc Bras Med Trop
Aim: To discuss the main findings regarding HRQoL in post-COVID-19 patients who required hospitalization.
CLINICAL CHARACTERISTICS
3/31/22
Abdel-Gawad M, Zaghloul MS, Abd-Elsalam S, et al. | Antiinflamm Antiallergy Agents Med Chem
Aim: To assess the prevalence of post-COVID-19 manifestations.
CLINICAL CHARACTERISTICS
3/31/22
de Oliveira YLM, de Sa Resende A, Martins-Filho PR, et al. | Inflammopharmacology
Aim: To evaluate the expression of TREM-1 in patients with COVID-19 and other viral pneumonias compared to healthy individuals.
CLINICAL CHARACTERISTICS
3/30/22
Almamlouk R, Kashour T, Obeidat S, et al. | Clin Microbiol Infect
Aim: To better understand the pathologic cardiac findings in COVID-19 patients at the time of postmortem evaluation.
CLINICAL CHARACTERISTICS
3/30/22
Zuin M, Bilato C, Quadretti L, et al. | G Ital Cardiol
Aim: To determine the in-hospital incidence of acute PE, based on Italian studies published on this issue.
CLINICAL CHARACTERISTICS
3/28/22
Asiimwe IG, Pushpakom SP, Turner RM, et al. | Br J Clin Pharmacol
Aim: To review the evidence on cardiovascular drug exposure and COVID-19 clinical outcomes.
CLINICAL CHARACTERISTICS
3/28/22
García H, Allende-López A, Morales-Ruíz P, et al. | Arch Med Res
Aim: To conduct a systematic review of the literature on published studies of COVID-19 in newborns with a positive RT–PCR test.
CLINICAL CHARACTERISTICS
3/28/22
Fabbri L, Moss S, Khan FA, et al. | Thorax
Aim: To assess the proportion of chest CT scans and pulmonary function tests consistent with parenchymal lung disease in the follow-up of people hospitalised with COVID-19 and viral pneumonitis.
CLINICAL CHARACTERISTICS
3/28/22
Maglietta G, Diodati F, Puntoni M, et al. | J Clin Med
Aim: To identify, in patients who had been hospitalized for COVID-19, which factors already present or emerging during hospitalization, were associated with an increased risk of exhibiting new or persisting symptoms.
UPDATED
CLINICAL CHARACTERISTICS
3/28/22
Gentile F, Bocci T, Coppola S, et al. | Biomedicines
Aim: To discuss current clinical and pre-clinical data on the relationship between the lung and brain during COVID-19.
CLINICAL CHARACTERISTICS
3/28/22
Riccò M, Ferraro P, Peruzzi S, et al. | Microorganisms
Aim: To summarize the available data about the risk of co-infections SARS-CoV-2–Legionella, specifically focusing on their prevalence, risk factors, and two main outcomes—ICU admission and case fatality ratio (CFR).
CLINICAL CHARACTERISTICS
3/28/22
Li S, Ren J, Hou H, et al. | Neurol Sci
Aim: To investigate the association between stroke and the risk for mortality among coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
3/28/22
Furnica C, Chistol RO, Chiran DA, et al. | Diagnostics
Aim: To evaluate the impact of the early COVID-19 pandemic on the presentation, management, and prognosis of STEMI patients.
UPDATED
CLINICAL CHARACTERISTICS
3/28/22
Decyk A, Kobylinska M, Antosik K, et al. | Rocz Panstw Zakl Hig
Aim: To review the current literature on the influence and importance of vitamin D levels on the course of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
3/25/22
Muthuka JK, Kiptoo M, Oluoch K, et al. | JMIR Pediatr Parent
Aim: To examine the relationship between pregnancy status and the clinical COVID -19 severity characterized by cytokine storm.
UPDATED
CLINICAL CHARACTERISTICS
3/25/22
Tan CJ, Tan BKJ, Tan XY, et al. | Laryngoscope
Aim: To review the evidence on the pathogenesis of COVID-19 olfactory dysfunction.
CLINICAL CHARACTERISTICS
3/24/22
Bhakta S, Erben Y, Sanghavi D, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To assess the association between race and VTE in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
3/24/22
Farsi Y, Tahvildari A, Arbabi M, et al. | Front Cell Infect Microbiol
Aim: To evaluate the composition of gut microbiota in COVID-19 patients compared with healthy individuals.
CLINICAL CHARACTERISTICS
3/24/22
Tutal E, Ozaras R, Leblebicioglu H | Travel Med Infect Dis
Aim: To assess the prevalence, clinical features and outcome of autoimmune thyroid disorders triggered by COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/21/22
Allotey J, Chatterjee S, Kew T, et al.  | BMJ
Aim: To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring.
CLINICAL CHARACTERISTICS
3/18/22
Kumar R, Rai AK, Phukan MM, et al. | Curr Genomics
Aim: To assess the cumulative risk assessment of multiple co-morbid conditions associated with severe COVID-19. 
CLINICAL CHARACTERISTICS
3/18/22
Ashktorab H, Russo T, Oskrochi G, et al. | Gastro Hep Adv
Aim: To analyze data from studies reporting Gastrointestinal bleeding (GIB) and/or endoscopic findings in COVID-19 patients in Western countries.
CLINICAL CHARACTERISTICS
3/18/22
Gatti M, Rinaldi M, Bussini L, et al. | Clin Microbiol Infect
Aim: To assess the clinical outcome in SOT recipients with COVID-19 compared to general population.
CLINICAL CHARACTERISTICS
3/18/22
Fatima M, Ahmad Cheema H, Ahmed Khan MH, et al.  | Ann Med Surg
Aim: To provide a detailed account of the development of myocarditis and pericarditis following the COVID-19 vaccination
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Hartwell M, Lin V, Gatewood A, et al.  | J Matern Fetal Neonatal Med
Aim: To examine the inclusion of the equity reporting in SRMAs focused on pregnancy outcomes and COVID-19 using PROGRESS-Plus equity framework.
CLINICAL CHARACTERISTICS
3/18/22
Gong X, Yuan B, Yuan Y | PLoS One
Aim: To assess the pooled incidence of pulmonary embolic events and the prognostic value of such events in intensive care unit (ICU) admissions of patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/22
Perez-Lopez FR, Saviron-Cornudella R, Chedraui P, et al. | J Matern Fetal Neonatal Med
Aim: To compare obstetric and perinatal outcomes in laboratory-tested pregnant women for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection before delivering.
CLINICAL CHARACTERISTICS
3/18/22
Qi X, Northridge ME, et al. | Aging Health Res
Aim: To determine the prevalence of oral health conditions in participants with COVID-19 infection and identify the associations of oral health conditions with COVID-19 related outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/18/22
Zou Y, Han M, Wang J, et al. | Ann Transl Med
Aim: To compare the mortality risk of frail vs. non-frail hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/22
Jaiswal V, Almas T, Peng Ang S, et al. | Ann Med Surg
Aim: To find the symptoms, risk factors, clinical findings, and outcomes in patient of COVID-19 having STEMI.
UPDATED
CLINICAL CHARACTERISTICS
3/14/22
Kaya T, Dilek A, Ozaras R, et al. | Travel Med Infect Dis
Aim: To evaluate COVID-19 cases presented with febrile neutropenia and provide information regarding incidence, clinical course and prognosis.
UPDATED
CLINICAL CHARACTERISTICS
3/14/22
Chen W, Yin C, Zhong M, et al. | Ann Palliat Med
Aim: To identify studies systematically that describe the incidence and outcome of COVID-19-related pulmonary aspergillosis (CAPA).
CLINICAL CHARACTERISTICS
3/14/22
Sharma P, Malik S, Wadhwan V, et al. | Rev Med Virol
Aim: To assess the prevalence of oral manifestations in COVID-19 confirmed individuals.
UPDATED
CLINICAL CHARACTERISTICS
3/11/22
Chen H, Shi H, Liu X, et al. | Front Med
Aim: To evaluate the effect of PR on lung impairment for patients with post-COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/10/22
Dao TL, Hoang VT, Colson P, et al. | J Clin Virol Plus
Aim: To determine the proportion of co-infection with influenza viruses in SARS-CoV-2 positive patients and to investigate the severity of COVID-19 in these patients.
CLINICAL CHARACTERISTICS
3/9/22
Wang Y, Li Y, Zhang Y, et al. | BMC Gastroenterol
Aim: To investigate the relationship between gastrointestinal symptoms and COVID-19 mortality.
CLINICAL CHARACTERISTICS
3/9/22
Alzoughool F, Abumweis S, Alanagreh L, et al. | Osong Public Health Res Perspect
Aim: To evaluate the association of pre-existing cardiovascular comorbidities, including hypertension and coronary heart disease, with coronavirus disease 2019 (COVID-19) severity and mortality.
CLINICAL CHARACTERISTICS
3/9/22
Balawender K, Pliszka A, Krowiak A, et al. | Curr Pharm Biotechnol
Aim: To present the current understanding of the effects of Covid-19 infection on the male genitourinary system.
CLINICAL CHARACTERISTICS
3/9/22
Wafa IA, Pratama NR, Sofia NF, et al. | Diabetes Metab J
Aim: To investigate the differences in metabolic control parameters in diabetic patients before and during the lockdown.
UPDATED
CLINICAL CHARACTERISTICS
3/9/22
Beigi-Khoozani A, Merajikhah A, Soleimani M | Chin Med Sci J
Aim: To review the evidence on magnetic resonance imaging findings of olfactory bulb in anosmic patients with COVID-19.
CLINICAL CHARACTERISTICS
3/9/22
Soltani S, Zandi M, Faramarzi S, et al.  | Osong Public Health Res Perspect
Aim: To determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients. 
CLINICAL CHARACTERISTICS
3/8/22
Martin-Martin J, Martin-Cazorla F, Suarez J, et al. | Curr Med Res Opin
Aim: To review complete autopsy cases and their postmortem findings and comorbidities associated with death caused by COVID-19.
CLINICAL CHARACTERISTICS
3/8/22
SeyedAlinaghi S, Karimi A, Barzegary A, et al. | Health Sci Rep
Aim: To review the evidence on mucormycosis co?infection in patients with COVID?19.
CLINICAL CHARACTERISTICS
3/7/22
Domingues RB, Leite FBVM, Senne C | Arq Neuropsiquiatr
Aim: To review the evidence on CSF findings relating to COVID-19.
CLINICAL CHARACTERISTICS
3/7/22
Hessami K, Aagaard K, Castro EC, et al. | Am J Perinatol
Aim: To review the evidence on histopathologic findings in the placentas of women with SARS-CoV-2 infection during pregnancy.
CLINICAL CHARACTERISTICS
3/7/22
Negrini F, de Sire A, Andrenelli E, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/4/22
Satpathy S, Wundaville LT, Satapathy S, et al. | J Patient Exp
Aim: To review the existing scales on patients’ satisfaction used for hospitalized patients and their application in COVID-19 situation. 
CLINICAL CHARACTERISTICS
3/4/22
Hu H, Pan H, Li R, et al. | Front Pharmacol
Aim: To identify the key factors associated to COVID-19 severity and death, especially in terms of the sex and race bias detected in severe COVID-19 patients.
CLINICAL CHARACTERISTICS
3/4/22
Krzych LJ, Putowski Z, Gruca K, et al. | Pol Arch Intern Med
Aim: To review the evidence on mortality in critically ill COVID-19 patients with fungal infections.
CLINICAL CHARACTERISTICS
3/4/22
Goyal M, Ray I, Mascarenhas D, et al. | QJM
Aim: To elucidate the clinical findings, laboratory parameters, treatment and outcomes of individuals with Myocarditis after COVID-19 vaccination.
UPDATED
CLINICAL CHARACTERISTICS
3/4/22
Quintero-Martinez JA, Hindy JR, Mahmood M, et al. | Am J Med Sci
Aim: To provide a descriptive analysis of the clinical features and outcomes of patients with IE and recent COVID-19.
CLINICAL CHARACTERISTICS
3/2/22
Nguyen B, Tosti A | JAAD Int
Aim: To characterize the types, incidence, timing, and clinical outcomes of COVID-19-associated alopecia.
CLINICAL CHARACTERISTICS
3/2/22
Notarte KI, Ver AT, Velasco JV, et al.  | Crit Rev Clin Lab Sci
Aim: To review the evidence on the possible effects of age, sex, serostatus, and comorbidities on humoral response (i.e. total antibodies, IgG, and/or IgA) of different populations post-mRNA-based Pfizer-BioNTech vaccination.
CLINICAL CHARACTERISTICS
3/2/22
Ben-Aicha S, Buchanan J, Punjabi P, et al. | Perfusion
Aim: To estimate the rate of in-hospital mortality following different treatments on COVID-19 in patients with CVD.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
Damara FA, Muchamad GR, Anton, et al. | World Neurosurg
Aim: To evaluate the epidemiological characteristics of TBI patients before and during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
3/2/22
Tayyebi H, Hasanikhah M, Heidarikhoo M, et al. | Curr Orthop Pract
Aim: To assess the in-hospital and 30-day mortality rates as well as the length of hospital stay in patients with COVID-19 infection who had hip fracture surgery.
CLINICAL CHARACTERISTICS
3/2/22
Pashaei Z, SeyedAlinaghi S, Qaderi K, et al. | Health Sci Rep
Aim: The possible complications of COVID?19 infection in the fetus and newborn babies including the possibility and evidence of vertical transmission.
CLINICAL CHARACTERISTICS
3/2/22
Hannah JR, Ali SS, Nagra D, et al.  | Clin Exp Rheumatol
Aim: To review the evidence on skeletal muscle involvement in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
Pathirathna ML, Samarasekara BPP, Dasanayake TS, et al. | Healthcare
Aim: To evaluate the maternal, fetal and neonatal effects associated with COVID-19 in pregnancy.
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
El-Qushayri AE, Kamel AMA, Reda A, et al. | Rev Med Virol
Aim: To give a summary of the available literature regarding the outcomes of dengue and COVID-19 co-infection.
CLINICAL CHARACTERISTICS
2/28/22
Szarpak L, Mierzejewska M, Jurek J, et al. | Biology
Aim: To determine the association between CAD and COVID-19 outcomes. 
CLINICAL CHARACTERISTICS
2/28/22
Oyelade T, Alqahtani JS, Hjazi AM, et al. | Trop Med Infect Dis
Aim: To assess the prevalence of people living with HIV (PLWH) among COVID-19 cases and whether HIV infection affects the risk of severe COVID-19 or related death at the global and continental level. 
CLINICAL CHARACTERISTICS
2/28/22
Kariyawasam JC, Jayarajah U, Abeysuriya V, et al. | Am J Trop Med Hyg
Aim: To outline the important liver manifestations of COVID-19 and discussed the possible underlying pathophysiological mechanisms and their diagnosis and management.
CLINICAL CHARACTERISTICS
2/28/22
Han Q, Zheng B, Daines L, et al. | Pathogens
Aim: To systematically synthesise existing evidence on long-term post-COVID symptoms.
CLINICAL CHARACTERISTICS
2/28/22
Tian Y, Lu H, Liu X, et al. | Medicine
Aim: To assess whether tricuspid annular plane systolic excursion (TAPSE) could be used as a prognostic tool in patients with coronavirus disease 19 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
2/28/22
Ng JW, Chong ETJ, Tan YA, et al. | Int J Environ Res Public Health
Aim: To provide insight into the prevalence of COVID-19 in 5 different clinical stages during the outset of the COVID-19 pandemic in Malaysia.
CLINICAL CHARACTERISTICS
2/28/22
Mendiola-Pastrana IR, López-Ortiz E, Río de la Loza-Zamora JG, et al. | Life
Aim: To analyze the impact of different SARS-CoV-2 variants on clinical outcomes.
CLINICAL CHARACTERISTICS
2/28/22
Halim C, Mirza AF, Sari MI | Pathogens
Aim: To determine the relationship, if any, between TNF-alpha, IL-6, vitamin D, and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
2/24/22
An W, Wang Q, Kim TE, et al. | J Infect Public Health
Aim: To investigate the clinical characteristics, morbidity, severity, and mortality of COVID-19 infection among solid organ transplant (SOT) recipients by meta-analysis.
CLINICAL CHARACTERISTICS
2/24/22
Li J, Wang Y, Liu Y, et al.  | Eur J Med Res
Aim: To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis.
UPDATED
CLINICAL CHARACTERISTICS
2/24/22
Isla A, Landy D, Teasdall R, et al. | Eur J Orthop Surg Traumatol
Aim: To explore the association of COVID-19 with short-term mortality in hip fracture patients.
CLINICAL CHARACTERISTICS
2/24/22
Fabião J, Sassi B, Pedrollo EF, et al. | Braz J Med Biol Res
Aim: To study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones.
UPDATED
CLINICAL CHARACTERISTICS
2/22/22
Heidary M, Asadi A, Noorbakhsh N, et al. | J Clin Lab Anal
Aim: To discuss the characteristics of COVID-19 in HIV-positive patients.
CLINICAL CHARACTERISTICS
2/22/22
Kamat M, Datar U, Byakodi S, et al. | J Clin Transl Res
Aim: To report and analyze CAM regarding risk factors, clinical characteristics and to understand the associated pathogenesis.
CLINICAL CHARACTERISTICS
2/22/22
Pandey SR, Adhikari Yadav S, Gautam S, et al. | F1000Res
Aim: To evaluate the clinical and radiological effects of LDRT in patients with severe acute respiratory syndrome (SARS) due to COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/21/22
Yelin D, Moschopoulos CD, Margalit I, et al. | Clin Microbiol Infect
Aim: To provide evidence-based recommendations for assessment and management of individuals with persistent symptoms after acute COVID-19 infection, and provide a definition for this entity, termed “long COVID”.
CLINICAL CHARACTERISTICS
2/21/22
Silveira FM, Mello ALR, da Silva Fonseca L, et al. | Arch Oral Biol
Aim: To integrate the morphological and tissue-based molecular characterization of oral lesions occurring in individuals infected by COVID-19 (OLICs).
UPDATED
CLINICAL CHARACTERISTICS
2/18/22
Yadav M, Singh A, Meena J, et al. | J Laryngol Otol
Aim: To review the evidence on the otorhinolaryngologic manifestations of COVID-19 in paediatric patients.
CLINICAL CHARACTERISTICS
2/18/22
Kazemi S, Pourgholaminejad A, Saberi A | Basic Clin Neurosci
Aim: To review the change of stroke incidence during the COVID-19 pandemic period and the proposed mechanisms of the relationship between SARS-CoV-2 and stroke.
CLINICAL CHARACTERISTICS
2/18/22
Hannum ME, Koch RJ, Ramirez VA, et al.  | Chem Senses
Aim: To establish the predicted prevalence rate of taste loss in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/17/22
Di Felice G, Visci G, Teglia F, et al. | Elife
Aim: To compare the outcomes of unvaccinated COVID-19 patients with and without cancer.
CLINICAL CHARACTERISTICS
2/17/22
Harwood R, Yan H, Talawila Da Camara N, et al.  | EClinicalMedicine
Aim: To identify which CYP were at increased risk of severe disease or death in CYP admitted to hospital with SARS-CoV-2 infection or PIMS-TS / MIS-C.
CLINICAL CHARACTERISTICS
2/16/22
Barzegar M, Mirmosayyeb O, Ebrahimi N, et al. | Mult Scler Relat Disord
Aim: To assess the risk of coronavirus disease (COVID-19), clinical features and outcome among patients with neuromyelitis optica spectrum disorder (NMOSD).
CLINICAL CHARACTERISTICS
2/16/22
Shah K, Varna VP, Sharma U, et al. | QJM
Aim: To study the effect of vitamin D supplementation on morbidity and mortality in hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
2/15/22
Elberry MH, Abdelgawad HAH, Hamdallah A, et al. | J Thromb Thrombolysis
Aim: To report susceptible demographics outcomes, commonalities, and prognosis of reporting cases. 
CLINICAL CHARACTERISTICS
2/15/22
Uaprasert N, Tangcheewinsirikul N, Rojnuckarin P, et al. | Blood Adv
Aim: To systematically review the clinical features and outcomes of patients with COVID-19 with confirmed HIT.
UPDATED
CLINICAL CHARACTERISTICS
2/14/22
Nguyen NN, Hoang VT, Dao TL, et al. | Eur J Clin Microbiol Infect Dis
Aim: To describe the burden of the long-term persistence of clinical symptoms in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/14/22
Xiao D, Tang F, Chen L, et al. | Front Cardiovasc Med
Aim: To evaluate the association between thrombosis and the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
2/14/22
Kariyawasam RM, Dingle TC, Kula BE, et al. | Clin Microbiol Infect
Aim: To review the prevalence, diagnosis, treatment, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) and compare research definitions.
CLINICAL CHARACTERISTICS
2/14/22
Bachour Y, Bekkenk MW, Rustemeyer T, et al. | J Cosmet Dermatol
Aim: To review the evidence on late inflammatory reactions in patients with soft tissue fillers after infection with SARS-CoV-2 and vaccination.
CLINICAL CHARACTERISTICS
2/14/22
Nagalli S, Kikkeri NS | Infez Med
Aim: To study the patient’s characteristics, risk factors, complications, and outcomes of COVID-19 patients diagnosed with mucormycosis.
CLINICAL CHARACTERISTICS
2/14/22
Alali AH, Smaisem MS, Alsheikh AM, et al. | Infez Med
Aim: To explore myocardial injury in coronavirus disease-19 (COVID-19) patients who were hospitalized with severe complicated infections.
CLINICAL CHARACTERISTICS
2/11/22
Quintanilla-Sánchez C, Salcido-Montenegro A, González-González JG, et al. | Rev Neurosci
Aim: To describe the prevalence and risk of ACVE in patients with severe and nonsevere COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
da Silva CGL, Santana JRP, Pinheiro LFG, et al. | Adv Exp Med Biol
Aim: To analyze the main morphofunctional changes in the involvement of multiple organs in patients infected with SARS-CoV-2, correlating anatomopathological findings with the clinical picture.
CLINICAL CHARACTERISTICS
2/11/22
Ramandi A, Akbarzadeh MA, Khaheshi I, et al. | Curr Probl Cardiol
Aim: To review articles inclusive of aortic dissection concurrent with Covid-19 infection.
CLINICAL CHARACTERISTICS
2/11/22
Jaiswal V, Nepal G, Dijamco P, et al. | J Prim Care Community Health
Aim: To systematically review the baseline features, clinical characteristics, treatment, and outcomes in patients developing CVST post-COVID-19 vaccination.
CLINICAL CHARACTERISTICS
2/11/22
Liu N, Yang D, Zhang T, et al. | Int J Infect Dis
Aim: To assess the risk factors for olfactory and gustatory dysfunction in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/11/22
Al Kiyumi MH, Kalra S, Davies JS, Kalhan A | Indian J Endocrinol Metab
Aim: To ascertain the prevalence of VDD in patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/9/22
Audrey J, Wisnu W, Tahapary DL | Curr Diabetes Rev
Aim: To investigate the association between statin use and poor outcomes in COVID-19 patients with diabetes.
CLINICAL CHARACTERISTICS
2/9/22
Han S, Zhuang Q, Chiang J, et al. | BMJ Open
Aim: To determine the proportion of COVID-19 patients with cancer, their severity and mortality outcomes through a systematic review and meta-analysis (MA).
CLINICAL CHARACTERISTICS
2/9/22
Al-Maiahy TJ, Al-Kuraishy HM, Al-Gareeb AI | J Pak Med Assoc
Aim: To illustrate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during pregnancy and to explore pregnancy outcomes, vertical and perinatal transmission as well as management of coronavirus disease-2019 (Covid-19) during pregnancy.
CLINICAL CHARACTERISTICS
2/9/22
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis | J Korean Med Sci
Aim: To identify children at high risk of severe COVID-19, with a focus on comorbidities and age.
CLINICAL CHARACTERISTICS
2/8/22
Alkodaymi MS, Omrani OA, Fawzy NA, et al. | Clin Microbiol Infect
Aim: To estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods.
CLINICAL CHARACTERISTICS
2/8/22
Baker J, Krishnan N, Abroms LC, et al. | J Smok Cessat
Aim: To determine whether a history of tobacco use increases risks for adverse outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
2/8/22
Tan Z, Huang S, Mei K, et al.  | Front Cardiovasc Med
Aim: To determine the prevalence and associated death of ventricular arrhythmia and sudden cardiac death (SCD) in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/7/22
Premraj L, Kannapadi NV, Briggs J, et al. | J Neruol Sci
Aim: To determine the prevalence of neurological and neuropsychiatric symptoms reported 12 weeks (3 months) or more after acute COVID-19 onset in adults.
CLINICAL CHARACTERISTICS
2/7/22
Duarsa MDVI, Kandarini Y, Yogiswara N, et al. | Truk J Urol
Aim: To systematically review the current findings regarding survival and clinical outcomes of KT recipients with COVID-19 infection.
CLINICAL CHARACTERISTICS
2/4/22
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize their clinical features, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
2/4/22
Malik J, Zaidi SMJ, Waqar AU, et al. | Expert Rev Endocrinol Metab
Aim: To assess the prevalence of hypothyroidism in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/4/22
Mir T, Attique HB, Sattar Y, et al.  | Cardiovasc Revasc Med
Aim: To evaluate the mortality outcomes of critically ill patients with and without PE (WPE).
CLINICAL CHARACTERISTICS
2/4/22
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate the pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS).
CLINICAL CHARACTERISTICS
2/4/22
Ouyang L, Gong J, Yu M | Int Immunopharmacol
Aim: To investigate the prevalence of ILD among patients with COVID-19 and figure out the relationship between ILD and the poor clinical outcomes of COVID-19.
CLINICAL CHARACTERISTICS
2/4/22
Prada L, D Santos C, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
CLINICAL CHARACTERISTICS
2/2/22
Sharma A, D Goel A, Bhardwaj P, et al. | Anaesthesiol Intensive Ther
Aim: To review the outcomes of coronavirus disease 2019 (COVID-19) patients who underwent tracheostomy.
CLINICAL CHARACTERISTICS
2/1/22
De Hert M, Mazereel V, Stroobants M, et al. | Front Psychiatry
Aim: To assess the risk of death associated with COVID-19 infection in people with SMI (schizophrenia spectrum disorders, BD, and MDD), compared with patients without SMI, or without any psychiatric disorder.
CLINICAL CHARACTERISTICS
2/1/22
Tian Y, Wu Q, Li H, et al. | Can Respir J
Aim: To review the evidence on the clinical characteristics of COVID-19 in patients based on geographical regions.
UPDATED
CLINICAL CHARACTERISTICS
2/1/22
Mohammed SA, Eid KM, Anyiam FE, et al.  | Egypt Liver J
Aim: To confirm the correlation of liver involvement in SARS-CoV-2 infection patients and detect the prognosis relationship with COVID-19 patients.
CLINICAL CHARACTERISTICS
2/1/22
Chivese T, Matizanadzo M, Musa O, et al. | Pathog Glob Health
Aim: To estimate the prevalence and longevity of detectable SARS-CoV-2 antibodies and T and B memory cells after recovery.
UPDATED
CLINICAL CHARACTERISTICS
1/31/22
Abbas AS, Hardy N, Ghozy S, et al. | Clin Neurol Neursurg
Aim: To assess the outcomes of invasive ventilation, mortality, and hospital length of stay (HLoS) for patients presenting with MG and COVID-19.
CLINICAL CHARACTERISTICS
1/31/22
Yang J, D'Souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To review the evidence on pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
UPDATED
CLINICAL CHARACTERISTICS
1/31/22
Pepera G, Tribali MS, Batalik L, et al. | Rev Cardiovasc Med
Aim: To assess the link between COVID-19 and cardiovascular risk factors, and investigate the prognosis in the case of myocardial injury.
UPDATED
CLINICAL CHARACTERISTICS
1/31/22
Haase KR, Verma R, Kilgour HM | Curr Opin Support Palliat Care
Aim: To summarize the literature on the impact of COVID-19 on older adults with cancer, including both the impacts of COVID-19 diagnosis on older adults with cancer and the implications of the pandemic on cancer care.
CLINICAL CHARACTERISTICS
1/28/22
Dar-Odeh N, Bobamuratova DT, Alnazzawi A, et al. | Cranio
Aim: To highlight jaw-related complications in COVID-19 manifestations, their etiology, and prevention methods.
CLINICAL CHARACTERISTICS
1/28/22
Singh R, Rathore SS, Khan H, et al. | Front Med
Aim: To investigate the association of ACEIs and ARBs used in COVID-19 and its effect on the mortality rate and severity of COVID-19.
CLINICAL CHARACTERISTICS
1/28/22
Bepouka B, Situakibanza H, Sangare M, et al. | J Clin Hypertens
Aim: To evaluate the magnitude of COVID-19 mortality in patients with hypertension in SSA.
CLINICAL CHARACTERISTICS
1/27/22
Díaz LA, García-Salum T, Fuentes-López E, et al. | Gastroenterol Hepatol
Aim: To assess the clearance time in stools of SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
1/27/22
Gil-Rodríguez J, Pérez de Rojas J, Aranda-Laserna P, et al. | Eur J Radiol
Aim: To identify the defining LUS findings of COVID-19, and to establish its association to the initial severity of the disease and prognostic outcomes.
UPDATED
CLINICAL CHARACTERISTICS
1/26/22
 | IRIS PAHO
Aim: To review the evidence on potential therapeutic options for COVID-19.
CLINICAL CHARACTERISTICS
1/25/22
Gupta P, Gupta M, KAtoch N, et al. | Int J Endocrinol Metab
Aim: To determine the overall mortality and diabetes-associated mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
1/25/22
Deb P, Zannat KE, Talukder S, et al. | HLA
Aim: To identify significant HLAs for their association with COVID 19. 
CLINICAL CHARACTERISTICS
1/25/22
Sathian B, Banerjee I, Mekkodathil AA, et al. | Nepal J Epidemiol
Aim: To review the evidence on the epidemiologic and clinical characteristics of COVID-19 in pregnant women.
CLINICAL CHARACTERISTICS
1/25/22
Subramaniam A, Shekar K, Afroz A, et al.  | Intern Med J
Aim: To examine associations between frailty and short-term mortality in patients hospitalised with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/25/22
Esmaeili M, Abdi F, Shafiee G, et al. | Int J Prev Med
Aim: To systematically review and pool all available evidence on the olfactory and gustatory dysfunction in COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
1/24/22
Wu HHL, Shenoy M, Kalra PA, et al. | Children
Aim: To delineate the range of intrinsic kidney pathologies that have manifested following acute COVID-19 infection in children.
CLINICAL CHARACTERISTICS
1/24/22
Miller JL, Tada M, Goto M, et al.  | Acad Emerg Med
Aim: To evaluate published reports of prediction models for severe illnesses caused COVID-19.
CLINICAL CHARACTERISTICS
1/24/22
Ledda C, Costantino C, Motta G, et al. | Trop Med Infect Dis
Aim: To provide evidence on mRNA reported vaccine breakthrough infections among HCP.
CLINICAL CHARACTERISTICS
1/24/22
Amiri-Dashatan N, Koushki M, Parsamanesh N, et al. | J Investig Med
Aim: To reassess the available findings on the association between cortisol level and severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
1/24/22
Chen Y, Li X, Dai Y, et al. | Front Endocrinol
Aim: To evaluate the effect of the severity of COVID-19 on thyroid-related hormones and the effect of thyroid-related hormones on the outcome of COVID-19.
CLINICAL CHARACTERISTICS
1/21/22
Bailey AJM, Kirkham AM, Monaghan M, et al. | Curr Oncol
Aim: To review the evidence on the clinical manifestations and outcomes of HCT recipients contracting COVID-19 at all stages following transplant, including both pediatric and adult recipients.
UPDATED
CLINICAL CHARACTERISTICS
1/21/22
Pranata R, Yonas E, Huang I, et al. | Eur J Gastroenterol Hepatol
Aim: To explore the association between the FIB-4 index and the risk of mortality among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
1/21/22
De Lorenzo A, Cenname G, Marchetti M, et al. | Eur Rev Med Pharmacol Sci
Aim: To highlight the relationship between nutritional quality and social inequalities related to CDNCD, obesity and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/19/22
Wong K, Farooq Alam Shah MU, Khurshid M, et al. | Ann Med Surg
Aim: To analyze the association of COVID-19 with vasculitis.
UPDATED
CLINICAL CHARACTERISTICS
1/19/22
George TP, Joy SS, Rafiullah M, et al. | Curr Diabetes Rev
Aim: To look into cytokine levels, prevalence of risk factors, and other comorbidities in COVID-19 patients with and without diabetes mellitus during the early COVID-19 outbreak.
CLINICAL CHARACTERISTICS
1/19/22
Qin R, He L, Yang Z, et al.  | Clin Rev Allergy Immunol
Aim: To provide an updated synthesis of the association between immune-related indicators and COVID-19 prognosis.
UPDATED
CLINICAL CHARACTERISTICS
1/18/22
Espinoza-Espinoza DAK, Dulanto-Vargas JA, Cáceres-LaTorre OA, et al. | J Int Soc Prev Community Dent
Aim: To evaluate the available evidence about a potential association between PD and the risk of COVID-19 complications.
UPDATED
CLINICAL CHARACTERISTICS
1/18/22
Ao G, Wang Y, Liu F, et al. | Exp Clin Transplant
Aim: To compare the clinical outcomes between kidney transplant recipients and patients on dialysis with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/17/22
Alharbi MG | Expert Rev Hematol
Aim: To review the evidence on COVID-19 infection associated with ITP.
CLINICAL CHARACTERISTICS
1/17/22
Hermansyah TA, Ginanjar E, Putri VH | Acta Med Indones
Aim: To summarize the prognosis of Corona Virus Disease 2019 (COVID-19) patients with elevated troponin and N-terminal pro brain natriuretic peptide (NT-proBNP) levels and demonstrate the involvement of myocardial injury as a complication in COVID-19.
CLINICAL CHARACTERISTICS
1/17/22
Shahzad M, Chaudhary SG, Zafar MU, et al. | Transpl Infect Dis
Aim: To investigate the impactof COVID-19 in HSCT recipients, including the severity of symptoms, treatment modalities used, and prognosis.
CLINICAL CHARACTERISTICS
1/17/22
Danwang C, Noubiap JJ, Robert A, et al. | AIDS Res Ther
Aim: To summarize the available information on the risk of hospitalization, severe disease, and death attributable to HIV in patients with COVID-19 and to determine the proportion of patients co-infected with HIV among patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/17/22
Singh A, Singh Y, Pangasa N, et al. | Indian J Crit Care Med
Aim: To highlight the risk factors, types, and outcomes of air leak in COVID-19.
CLINICAL CHARACTERISTICS
1/14/22
Rosário Ferreira ME, Santos de Andrade AV, Ferreira Queiroz AA, et al.  | EXCLI J
Aim: To review the evidence on the clinical and laboratory characteristics, associated comorbidities, and outcomes of obese patients with COVID-19.
CLINICAL CHARACTERISTICS
1/13/22
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19. 
CLINICAL CHARACTERISTICS
1/13/22
Reddy SGK, Mantena M, Garlapati SKP, et al. | J Pharm Bioallied Sci
Aim: To determine the pooled estimations in the clinical features and prognosis along with the subgroups based on the severity of the disease in various regions of the world.
CLINICAL CHARACTERISTICS
1/13/22
Macpherson K, Cooper K, Harbour J, et al. | BMJ Open
Aim: To explore the experiences of people living with long COVID and how they perceive the healthcare services available to them.
CLINICAL CHARACTERISTICS
1/13/22
Soltani S, Zandi M, Ahmadi SE, et al. | Iran J Med Sci
Aim: To identify ophthalmic symptoms of COVID-19 patients and establish an association between these symptoms and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/12/22
Dzinamarira T, Murewanhema G, Mhango M, et al. | Int J Environ Res Public Health
Aim: To map and analayse the available global evidence on the prevalence of SARS-CoV-2 infections among healthcare workers. 
CLINICAL CHARACTERISTICS
1/12/22
Jdiaa SS, Mansour R, El Alayli A, et al. | J Nephrol
Aim: To summarize the effect of CKD on different outcomes among patients with COVID–19. 
UPDATED
CLINICAL CHARACTERISTICS
1/12/22
Zuin M, Roncon L, Zuliani G. | J Cardiovasc Med
Aim: To compare the echocardiographic systolic pulmonary arterial pressure (sPAP) difference between COVID-19 survivors (S) and nonsurvivors (NS).
CLINICAL CHARACTERISTICS
1/11/22
Salman MA, Mallah SI, Khalid W, et al. | Int J Gen Med
Aim: To investigate the clinical characteristics of patients whose cerebrospinal fluid (CSF) tested positive for SARS-CoV-2.
CLINICAL CHARACTERISTICS
1/11/22
Pranata R, Huang I, Lim MA, et al. | Front Med
Aim: To assess whether elevated De Ritis ratio is associated with poor prognosis in patients with coronavirus 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Shrestha DB, Sedhai YR, Budhathoki P, et al. | Ann Med Surg
Aim: To assess the value and significance of spontaneous pulmonary barotrauma such as pneumothorax, pneumomediastinum, and subcutaneous emphysema in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Schlage S, Lehrnbecher T, Berner R, et al. | Eur J Pediatr
Aim: To update the available information on SARS-CoV-2 infections in pediatric cancer patients.
CLINICAL CHARACTERISTICS
1/11/22
Hernández-Vásquez A, Chavez-Ecos F, Barrenechea-Pulache A, et al. | PeerJ
Aim: To estimate the seroprevalence and lethality attributable to SARS-CoV-2 in the indigenous population of LAC.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Ogungbe O, Kumbe B, Fadodun O, et al. | Int J Cardiol Heart Vasc
Aim: To quantify the association between biomarkers of myocardial injury (troponin), myocardial stretch (NT-proBNP, Gal-3), coagulation (D-Dimer), inflammation (CRP, IL-6) and severe COVID-19 or death in hospitalized patients.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Marchand G, Patil AS, Masoud AT, et al. | AJOB Glob Rep
Aim: To review the evidence on the maternal and neonatal outcomes in pregnant women infected with the Coronavirus Disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
1/11/22
Hada M, Mosholder AD, Leishear K, et al. | Neurol Sci
Aim: To examine the available data on U.S. therapies approved to treat MS and the risk of SARS-CoV-2 infection or severe COVID-19 outcomes. 
CLINICAL CHARACTERISTICS
1/11/22
Mahmoudi E, Mollazadeh R, Mansouri P, et al. | Clin Cardiol
Aim: To evaluate electrocardiogram (ECG) markers of repolarization heterogeneity in patients hospitalized with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/11/22
Chiodini I, Gatti D, Soranna D, et al. | Front Public Health
Aim: To investigate whether vitamin D status is associated with the COVID-19 severity, defined as ARDS requiring admission to intensive care unit (ICU) or mortality (primary endpoints) and with the susceptibility to SARS-CoV-2 and COVID-19-related hospitalization (secondary endpoints).
CLINICAL CHARACTERISTICS
1/10/22
Omar M, Youssef MR, Trinh LN, et al. | Birth
Aim: To evaluate variations in clinical presentation, laboratory findings, and maternal/neonatal outcomes in COVID-19 patients who delivered vaginally versus via cesarean.
CLINICAL CHARACTERISTICS
1/6/22
Amirian A, Pakzad R, Hasanpour V, et al. | J Matern Fetal Neonatal Med
Aim: To investigate neonatal outcomes among pregnant women with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/5/22
Molaee H, Emadi SN, M'Imunya JMN, et al. | Dermatol Ther
Aim: To investigate chilblain-like lesions in children during the COVID-19 pandemic, any predisposition, location, clinical course, and prognosis.
CLINICAL CHARACTERISTICS
1/5/22
Cui Y, Zhao B, Li T, et al. | Brain Res Bull
Aim: To evaluate the association between the risk of ischemic stroke and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/4/22
Bhattacharyya A, Sarma P, Kaur H, et al. | Indian J Pharmacol
Aim: To review the evidence on the demographic and clinical profile, risk factors, impact of different interventions, and outcomes among C-ROCM cases.
CLINICAL CHARACTERISTICS
1/3/22
Ceban F, Ling S, Lui LMW, et al. | Brain Behav Immun
Aim: To quantify the proportion of individuals experiencing fatigue and cognitive impairment 12 or more weeks following COVID-19 diagnosis, and to characterize the inflammatory correlates and functional consequences of post-COVID-19 syndrome.
UPDATED
CLINICAL CHARACTERISTICS
1/3/22
Changal K, Veria S, Mack S, et al. | BMC Cardiovasc Disord
Aim: To review the evidence on the effect of myocardial injury on the clinical outcome of patients hospitalized with COVID-19. 
CLINICAL CHARACTERISTICS
1/3/22
Kheyrandish S, Rastgar A, Arab-Zozani M, et al. | Front Med
Aim: To review the evidence on portal vein thrombosis development through COVID-19 infection or vaccination.
CLINICAL CHARACTERISTICS
1/3/22
Jahan N, Brahma A, Kumar MS, et al. | Int J Infect Dis
Aim: To summarize the seroprevalence of SARS-CoV-2 and quantitatively estimate the pooled seroprevalence of SARS-CoV-2 among the Indian population.
UPDATED
CLINICAL CHARACTERISTICS
12/31/21
Zulkarnain Z, Nuryati A, Upix D, et al. | Journal of Health Policy and Management
Aim: To examine the association between gender and anxiety among COVID-19 patients.
CLINICAL CHARACTERISTICS
12/31/21
Jaiswal V, Alquraish D, Sarfraz Z, et al. | J Prim Care Community Health
Aim: To provide thorough analyses of associations between COVID-19 and neurological outcomes for patients with PD.
CLINICAL CHARACTERISTICS
12/30/21
Wang F, Boros S | Baltic Journal of Health and Physical Activity
Aim: To review the evidence of mental and physical health consequences during COVID-19 pandemic.
CLINICAL CHARACTERISTICS
12/30/21
Ali NA, Khoja A, Kazim F | Turk Psikiyatri Derg
Aim: To highlight the role of telemental health services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
12/29/21
Guan Z, Chen C, Li Y, et al. | Front Public Health
Aim: To evaluate the impact of coinfection with SARS-CoV-2 and influenza on mortality, critical outcomes involving shock, being admitted to ICU or requiring ventilatory support, as well as relevant clinical symptoms and laboratory index compared with mono-infections of SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/29/21
Dashti S, Bolghanabadi N, Ghavami V, et al.  | J Sex Marital Ther
Aim: To review the evidence on the impact of the COVID-19 pandemic on female sexual function.
CLINICAL CHARACTERISTICS
12/29/21
Viner R, Waddington C, Mytton O, et al. | J Infect
Aim: To review the evidence on the extent that children and young people (CYP) under 20 years of age transmit SARS-CoV-2 to other CYP and to adults in household and child-specific (e.g. educational) settings.
UPDATED
CLINICAL CHARACTERISTICS
12/29/21
Amanollahi A, Sotoodeh Ghorbani S, Basir Ghafouri H, et al. | Med J Islam Repub Iran
Aim: To systematically assess and estimate the clinical, laboratory, and imaging features related to COVID-19.
CLINICAL CHARACTERISTICS
12/27/21
Jennings G, Monaghan A, Xue F, et al. | J Clin Med
Aim: To compare the two phases of long COVID, namely ongoing symptomatic COVID-19 and post-COVID-19 syndrome with respect to symptomatology, abnormal functioning, psychological burden, and quality of life.
UPDATED
CLINICAL CHARACTERISTICS
12/27/21
Cuevas-Gonzalez MV, Espinosa-Cristóbal LF, Donohue-Cornejo A, et al. | Medicine
Aim: To identify the main signs and symptoms of COVID-19 in the oral cavity.
UPDATED
CLINICAL CHARACTERISTICS
12/27/21
Moreno-Sánchez E, Castillo-Viera E, Vélez-Moreno E, et al. | Medicina
Aim: To analyse the factors that affect the probability of the paediatric asthma population suffering from COVID-19 or SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/27/21
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G | Cells
Aim: To analyze the current data regarding the new-onset systemic and rheumatic autoimmune diseases in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/27/21
Menezes RG, Rizwan T, Saad Ali S, et al. | Leg Med
Aim: To identify studies reporting gross, histological, microscopic, and immunohistochemical findings on postmortem examination of COVID-19 patients. 
CLINICAL CHARACTERISTICS
12/24/21
Chen H, Yang G, Long Y, et al. | Evid Based Complement Alternat Med
Aim: To determine the role of lymphocyte and platelet counts as well as interleukin-6 levels as predictors of death in patients with COVID-19.
CLINICAL CHARACTERISTICS
12/24/21
Rico-Martin S, Calderon-Garcia JF, Basilio-Fernandez B, et al. | J Cardiovasc Dev Dis
Aim: To investigate the relationship between metabolic syndrome (MetS) and its components with SARS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/24/21
Bradley SA, Banach M, Alvarado N, et al. | J Diabetes
Aim: To determine the prevalence of diabetes in hospitalized COVID-19 patients and investigate the association of diabetes severe COVID-19, rate of acute respiratory distress syndrome (ARDS), mortality, and need for mechanical ventilation.
CLINICAL CHARACTERISTICS
12/24/21
Cai X, Wu G, Zhang J, et al. | Front Med
Aim: To analyse the risk factors for AKI in adult patients with COVID-19.
CLINICAL CHARACTERISTICS
12/24/21
McIntyre KM, Favre NM, Kuo CC, et al. | Cureus
Aim: To identify novel coronavirus disease 2019 (COVID-19) patients with a diagnosis of sudden sensorineural hearing loss (SSNHL) with an aim to describe possible mechanisms.
CLINICAL CHARACTERISTICS
12/24/21
Tomerak S, Khan S, Almasri M, et al. | Scand J Immunol
Aim: To compile clinical data of COVID-19 patients who developed thrombotic complications to investigate the possible role of hyperinflammation in inducing hypercoagulation. 
CLINICAL CHARACTERISTICS
12/23/21
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review the evidence from interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
12/23/21
Bastos SNMAN, Barbosa BLF, Cruz LGB, et al. | Rev Bras Ginecol Obstet
Aim: To analyze the clinical and obstetric aspects of pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
12/23/21
Mehrdad R, Zahra K, Mansouritorghabeh H | Clin Appl Thromb Hemost
Aim: To determine the levels of fibrinogen, D-dimer and FDP in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/23/21
Otunla A, Rees K, Dennison P, et al. | BMJ Evid Based Med
Aim: To determine if and to what degree asthma may predispose to worse COVID-19 outcomes in order to inform treatment and prevention decisions, including shielding and vaccine prioritisation.
CLINICAL CHARACTERISTICS
12/22/21
Hussain N, Agarwala P, Iqbal K, et al.  | J Med Virol
Aim: To compile and illustrate the clinical characteristics, physical examination findings, outcomes, and possible pathology behind acute TE occurring in COVID-19 recovered patients.
CLINICAL CHARACTERISTICS
12/22/21
Koupaei M, Naimi A, Moafi N, et al. | Front Med
Aim: To evaluate the various aspects such as symptoms, diagnosis, treatment, and mortality rate.
CLINICAL CHARACTERISTICS
12/22/21
Vidya G, Kalpana M, Roja K, et al. | Maedica
Aim: To examine the evidence on the clinical presentation of COVID-19 in children.
CLINICAL CHARACTERISTICS
12/22/21
Jafari M, Dastgheib SA, Ferdosian F, et al. | Hematol Transfus Cell Ther
Aim: To evaluate the proportion of hematological cancer patients with the SARS-CoV-2 infection during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
12/20/21
Jacobs JW, Booth GS | Am J Clin Pathol
Aim: To summarize the epidemiologic, clinical, and laboratory characteristics of autoimmune hemolytic anemia (AIHA) secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination.
CLINICAL CHARACTERISTICS
12/20/21
Stainer A, Amati F, Suigo G, et al. | Semin Respir Crit Care Med
Aim: To describe clinical picture, disease severity, proposed treatment regimen, and response to vaccination in patients with different types and severity of immunosuppression.
CLINICAL CHARACTERISTICS
12/20/21
Romero Starke K, Reissig D, Petereit-Haack G, et al. | BMJ Glob Health
Aim: To quantify the isolated effect of age on hospitalisation, admission to intensive care unit (ICU), mechanical ventilation and death.
UPDATED
CLINICAL CHARACTERISTICS
12/17/21
Gagelmann N, Passamonti F, Wolschke C, et al. | Haematologica
Aim: To systematically analyse the outcomes of patients with haematological malignancies who received vaccination and to identify specific groups with differences in outcomes. 
CLINICAL CHARACTERISTICS
12/17/21
Bilotta C, Perrone G, Adelfio V, et al. | Front Immunol
Aim: To analyze published cases of thrombosis after COVID-19 vaccinations to identify patients’ features, potential pathophysiological mechanisms, timing of appearance of the adverse events, and other critical issues.
CLINICAL CHARACTERISTICS
12/17/21
Castillo-Perez M, Jerjes-Sanchez C, Castro-Varela A, et al.  | Thromb J
Aim: To determine the therapeutic trends and outcomes in VTE COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
12/17/21
Dhillon RA, Qamar MA, Gilani JA, et al. | Ann Med Surg
Aim: To assess the determinants and disease spectrum of COVID-19 reinfection.
UPDATED
CLINICAL CHARACTERISTICS
12/16/21
You Y, Niu Y, Sun F, et al. | BMJ Open
Aim: To evaluate the impact of the COVID-19 pandemic on stroke hospitalisations, especially haemorrhagic stroke.
CLINICAL CHARACTERISTICS
12/16/21
Mao YJ, Wang WW, Ma J, et al. | Chin Med J
Aim: To assess the incidence of SARS-CoV-2 reinfection and the protection effect of previous infection against reinfection.
CLINICAL CHARACTERISTICS
12/16/21
Rungjirajittranon T, Owattanapanich W, Leelakanok N, et al. | Clin Appl Thromb Hemost
Aim: To better understand the incidence of thrombosis, bleeding, and mortality rates among patients discharged after COVID-19 hospitalization.
CLINICAL CHARACTERISTICS
12/15/21
van Reekum EA, Rosic T, Sergeant A, et al. | J Med Case Rep
Aim: To synthesize neuropsychiatric outcomes of COVID-19 in people with preexisting psychiatric disorders.
CLINICAL CHARACTERISTICS
12/15/21
Ma Q, Liu J, Liu Q, et al. | JAMA Netw Open
Aim: To evaluate the percentage of asymptomatic infections among individuals undergoing testing (tested population) and those with confirmed COVID-19 (confirmed population).
CLINICAL CHARACTERISTICS
12/15/21
Dadras O, Afsahi AM, Pashaei Z, et al. | Immun Inflamm Dis
Aim: To systematically review the association between SARS-CoV-2 viral load and COVID-19 severity.
CLINICAL CHARACTERISTICS
12/14/21
Abu-Amara J, Szpecht D, Al-Saad SR, et al. | Arch Med Sci
Aim: To assess the relationship of COVID-19 with the early gestational trimesters of pregnancy.
CLINICAL CHARACTERISTICS
12/14/21
Hosseini SF, Behnam-Roudsari S, Alavinia G, et al. | J Res Med Sci
Aim: To determine whether clinicians used these scoring systems while assessing COVID-19 patients and the role of relevant biomarkers in disease severity and outcome.
CLINICAL CHARACTERISTICS
12/14/21
Zuin M, Engelen MM, Barco S, et al. | Thromb Res
Aim: To estimate the incidence of VTE after hospital discharge among COVID-19 patients.
CLINICAL CHARACTERISTICS
12/14/21
Naderi N, Rahimzadeh M | Virology
Aim: To determine whether KL-6 could be used as a prognostic factor for severe COVID-19.
CLINICAL CHARACTERISTICS
12/14/21
Szarpak L, Filipiak KJ, Skwarek A, et al. | Cardiol J
Aim: To determine the impact of AF/atrial flutter (AFL) on mortality, as well as individual complications in patients hospitalized with the coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
12/13/21
Ebrahimzadeh A, Mohseni S, Narimani B, et al. | Crit Rev Food Sci Nutr
Aim: To review the evidence on the association between vitamin D status and risk of COVID-19 in-hospital mortality among observational studies.
CLINICAL CHARACTERISTICS
12/13/21
Damayanthi HDWT, Prabani KIP, Weerasekara I | Gerontol Geriatr Med
Aim: To identify various factors associated with mortality among older people infected with COVID-19.
CLINICAL CHARACTERISTICS
12/13/21
Agolli A, Agolli O, Velazco DFS, et al.  | Avicenna J Med
Aim: To understand the role of COVID-19 infection in causing pregnancy complications specifically fatal outcomes.
CLINICAL CHARACTERISTICS
12/13/21
Alenezi FK, Almeshari MA, Mahida R, et al. | Ren Fail
Aim: To assess the incidence and risk factors of AKI, need for kidney replacement therapy (KRT), and mortality rate among COVID-19 patients with and without ARDS from the first wave of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/13/21
Orilisi G, Mascitti M, Togni L, et al. | Int J Environ Res Public Health
Aim: To investigate the frequency of oral manifestations in COVID-19 hospitalized patients.
CLINICAL CHARACTERISTICS
12/13/21
Chen MY, Xiao FP, Kuai L, et al. | Am J Emerg Med
Aim: To provide a comprehensive description of the impact of AF on the prognosis of patients with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
12/13/21
Sharma D, Bhaskar SMM | APMIS
Aim: To determine a pooled prevalence estimate of PHICs in paediatric and adolescent hospitalised patients admitted for treatment due to COVID-19.
CLINICAL CHARACTERISTICS
12/13/21
Abrokwa SK, Müller SA, Méndez-Brito A, et al. | PLoS One
Aim: To review the evidence on the extent and characteristics of reinfections and re-positive rates of SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/9/21
Chen X, Huang Z, Wang J, et al. | BMJ Open
Aim: To estimate the rate of asymptomatic COVID-19 from published studies and compare this rate among different regions and patient groups.
CLINICAL CHARACTERISTICS
12/9/21
Tiwari S, Kc N, Thapa S, et al. | Middle East Fertil Soc J
Aim: To analyze the overall consequences of COVID-19 on semen parameters and male sex hormones.
UPDATED
CLINICAL CHARACTERISTICS
12/7/21
Al Maqbali M, Al Badi K, Al Sinani M, et al. | Biol Res Nurs
Aim: To identify the prevalence of the clinical symptoms of patient with COVID-19.
CLINICAL CHARACTERISTICS
12/7/21
Jackson WM, Price JC, Eisler L, et al. | J Neurosurg Anesthesiol
Aim: To assess the scope of diagnosis, treatment, and management of COVID-19 in pediatric patients.
CLINICAL CHARACTERISTICS
12/7/21
Santos MO, Gonçalves LC, Silva PAN, et al. | J Pediatr
Aim: To describe the main symptoms of MIS-C and characterize its treatment and possible outcomes.
UPDATED
CLINICAL CHARACTERISTICS
12/7/21
Jeyalan V, Storrar J, Wu HHL, et al. | World J Transplant
Aim: To provide an overview of the current literature on the renal histopathological features and mechanistic insights described in association with coronavirus disease 2019 (COVID-19) infection.
UPDATED
CLINICAL CHARACTERISTICS
12/7/21
Ma C, Tu D, Gu J, et al.  | Front Cardiovasc Med
Aim: To explore the predictive value of elevated Mb for adverse outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/6/21
Ikeagwulonu RC, Ugwu NI, Ezeonu CT, et al. | West Afr J Med
Aim: To provide evidence that will guide clinical management by reviewing studies that assessed CRP concentration and COVID-19 severity/outcome.
CLINICAL CHARACTERISTICS
12/6/21
McDaniel CG, Commander SJ, DeLaura I, et al. | J Pediatr Hematol Oncol
Aim: To review the evidence on coagulation abnormalities and clinical complications in children With SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/6/21
Yadav DK, Adhikari VP, Ling Q, et al. | Front Med
Aim: To approximate the prognosis of LT recipients with COVID-19 on the standard maintenance IS.
CLINICAL CHARACTERISTICS
12/6/21
Patrucco F, Zeppegno P, Baricich A, et al. | Minerva Med
Aim: To review systematically emerging evidence about clinical and functional consequences of Covid-19 pneumonia months after hospital discharge.
CLINICAL CHARACTERISTICS
12/6/21
Yu T, Wang H, Zheng S, et al. | Infect Drug Resist
Aim: To perform a comprehensive review and identify clinical cases with COVID-19 complicated by CVD to establish possible demographic, clinical, laboratory patterns, and prognostic features of these cases. 
CLINICAL CHARACTERISTICS
12/3/21
Jaiswal V, Sarfraz Z, Sarfraz A, et al. | J Prim Care Community Health
Aim: To collate current evidence about demographics, symptomatology, diagnostic, and clinical outcomes of COVID-19 infected patients with myocarditis.
CLINICAL CHARACTERISTICS
12/3/21
Khan DSA, Hamid LR, Ali A, et al. | BMC Pregnancy Childbirth
Aim: To assess differences in risk factors, management, complications, and pregnancy and perinatal outcomes in symptomatic vs. asymptomatic pregnant women with confirmed SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
12/2/21
Rindi LV, Moghazi SA, Donno DR, et al. | Int J Infect Dis
Aim: To summarize the literature on predicting rules for PE in hospitalized COVID-19 patients (HCPs).
CLINICAL CHARACTERISTICS
12/2/21
Pakzad R, Malekifar P, Shateri Z, et al. | J Clin Lab Anal
Aim: To evaluate the pathogens' coinfection prevalence among COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
12/1/21
Granata G, Petrosillo N, Al Moghazi S, et al.  | Anaerobe
Aim: To assess the proportion of confirmed COVID-19 patients with Clostridioides difficile infection (CDI) and to describe risk factors and outcome of these patients.
CLINICAL CHARACTERISTICS
11/30/21
Siahaan YMT, Ketaren RJ, Hartoyo V, et al. | Epilepsy Behav
Aim: To analyze whether patients with epilepsy have an increased risk of having poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
11/30/21
Zuin M, Rigatelli G, Quadretti L, et al. | Infect Dis Rep
Aim: To assess the prevalence and mortality risk in COVID-19 patients with anemia.
CLINICAL CHARACTERISTICS
11/30/21
Iftikhar S, Rehman AU, Ameer MZ, et al. | Ann Med Surg
Aim: To review the evidence on COVID-19-related-PRES from both clinical and pathophysiological standpoint.
CLINICAL CHARACTERISTICS
11/29/21
Yusof W, Irekeola AA, Wada Y, et al. | Life
Aim: To provide a global mutational profile of SARS-CoV-2 from December 2019 to October 2020.
UPDATED
CLINICAL CHARACTERISTICS
11/29/21
Hussain S, Riad A, Singh A, et al.  | J Fungi
Aim: To compute the pooled prevalence of CAM and other associated clinical outcomes.
CLINICAL CHARACTERISTICS
11/29/21
Etemadifar M, Nouri H, Maracy MR, et al. | Rev Neurol
Aim: To gather, synthesize, and meta-analyze data regarding the risk factors associated with a severe course of COVID-19 among patients with multiple sclerosis (pwMS).
CLINICAL CHARACTERISTICS
11/26/21
Khanijahani A, Iezadi S, Gholipour K, et al. | Int J Equity Health
Aim: To systematically review the evidence on the association of racial/ethnic and socioeconomic status (SES) with health outcomes and access to healthcare services during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
11/25/21
Zhang C, Chu H, Pei YV, et al. | Front Glob Womens Health
Aim: To evaluate the effects of COVID-19 among SARS-CoV-2-positive pregnant women in late pregnancy and neonates with SARS-CoV-2-positive pregnant mothers using blood assays to find indicators of maternal and neonatal complications. 
CLINICAL CHARACTERISTICS
11/25/21
Behnood SA, Shafran R, Bennett SD, et al. | J Infect
Aim: To estimate the prevalence of persistent symptoms following SARS-CoV-2 infection compared with uninfected controls and to identify potential risk factors associated with development of post-COVID symptoms in CYP.
CLINICAL CHARACTERISTICS
11/25/21
Senia P, Vella F, Mucci N, et al. | Exp Ther Med
Aim: To analyze the causes of mortality associated with SARS-CoV-2 infection in general, with particular focus on the result of infection in a professional environment.
CLINICAL CHARACTERISTICS
11/23/21
Guven DC, Sahin TK, Kilickap S, et al. | Front Oncol
Aim: To evaluate the antibody responses to COVID-19 in cancer patients.
CLINICAL CHARACTERISTICS
11/23/21
Asif AA, Hussain H, Senthil Kumaran S, et al. | J Community Hosp Intern Med Perspect
Aim: To assess efficacy of subcutaneous IFN-beta in regards to mortality and discharge rate.
CLINICAL CHARACTERISTICS
11/23/21
Ahmad S, Sohail A, Shahid Chishti MA, et al. | J Taibah Univ Med Sci
Aim: To determine whether the prevalence of OGD is sufficiently high in COVID-19 to justify their use as screening tools for this disease.
CLINICAL CHARACTERISTICS
11/23/21
Conway R, Grimshaw AA, Konig MF, et al. | Arthritis Rheumatol
Aim: To quantify the risk for SARS-CoV-2 infection and describe clinical outcomes of COVID-19 in people with RMD.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Meng Y, Wang J, Wen K, et al. | Biomed Res Int
Aim: To present systematic reviews and detailed estimates of the major symptoms of COVID-19, determine the prevalence of serious comorbidities, and assess patient progression via comorbidities, major symptoms and laboratory examination to help severe patients and effectively reduce the mortality of COVID-19 under the condition of limited medical resources.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, et al. | Eur J Cancer
Aim: To assess seroconversion rates based on anti-S IgG titres after partial and complete COVID-19 immunisation among oncological patients compared with non-cancer participants.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Nagarajan R, Krishnamoorthy Y, Basavarachar V, et al. | J Affect Disord
Aim: To estimate the prevalence of PTSD among the severe cases of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/22/21
Zinellu A, Paliogiannis P, Carru C, et al. | Clin Exp Med
Aim: To investigate serum concentrations of hydroxybutyrate dehydrogenase (HBDH), a combined marker of myocardial and renal injury, in hospitalized COVID-19 patients with different disease severity and survival status.
UPDATED
CLINICAL CHARACTERISTICS
11/19/21
Nascimento RB, Araujo NS, Silva JC, et al. | Spec Care Dentist
Aim: Evaluate oral manifestations detected in children with MIS-C and KD associated to COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/18/21
Khoshnood RJ, Zali A, Tafreshinejad A, et al. | Neurol Sci
Aim: To update the pooled prevalence of COVID-19 infection in patients with PD.
CLINICAL CHARACTERISTICS
11/18/21
Daly SR, V Nguyen A, Zhang Y, et al. | Brain Hemorrhages
Aim: To explore current literature on the association between COVID-19 and intracranial hemorrhage (ICH).
CLINICAL CHARACTERISTICS
11/17/21
Debi H, Itu ZT, Amin MT, et al. | Expert Rev Endocrinol Metab
Aim: To investigate the association of serum CRP and D-dimer concentration with COVID-19 severity in diabetic and non-diabetic patients.
CLINICAL CHARACTERISTICS
11/17/21
Shahsanayi F, Gharibzadeh A, Petrudi NR | Curr Probl Cardiol
Aim: To systematically assess the clinical sequels as well ascardiovascular findings in patients suffering STEMI following Covid-19.
CLINICAL CHARACTERISTICS
11/17/21
Ramzi ZS | Am J Emerg Med
Aim: To perform a systematic review and meta-analysis on the prevalence of one-year hospital readmissions and post-discharge all-cause mortality in recovered COVID-19 patients. 
CLINICAL CHARACTERISTICS
11/17/21
Seligman WH, Fialho L, Sillett N, et al. | BMJ Open
Aim: To develop a standardised minimum set of outcomes for clinical care.
CLINICAL CHARACTERISTICS
11/16/21
Du P, Chen W, Luo X, et al. | Ann Palliat Med
Aim: To compare the time intervals from onset to first medical visit and onset to the hospitalization of COVID-19 patients in different regions and assess the supply and demand status of medical resources.
UPDATED
CLINICAL CHARACTERISTICS
11/16/21
Xie Q, Tang S, Li Y | Ann Palliat Med
Aim: To evaluate the safety and efficacy of administering ACEIs and ARBS to patients with COVID-19.
CLINICAL CHARACTERISTICS
11/15/21
Gutiérrez-Valencia M, Leache L, Librero J, et al. | Transfusion
Aim: To synthesize the evidence on the association between ABO and the risk of COVID-19 infection and prognosis.
CLINICAL CHARACTERISTICS
11/15/21
de Medeiros KS, Sarmento ACA, Costa APF, et al. | Int J Gynaecol Obstet
Aim: To clarify the clinical features of COVID-19 and analyze maternal/fetal morbidity and mortality and the obstetric and neonatal outcomes of pregnant patients.
CLINICAL CHARACTERISTICS
11/15/21
Meyer HJ, Wienke A, Surov A | Acad Radiol
Aim: To elucidate the influence of non-pulmonary findings of thoracic computed tomography (CT) on unfavorable outcomes and in-hospital mortality in COVID-19 patients based on a large patient sample.
CLINICAL CHARACTERISTICS
11/15/21
Roy S, Demmer RT | Transl Res
Aim: To review the evidence on the interplay between impaired glucose regulation, diabetes mellitus and SARS-CoV-2.
CLINICAL CHARACTERISTICS
11/15/21
Chen JJ, Kuo G, Lee TH, et al. | J Clin Med
Aim: To explore the rate of mortality, intensive care unit admission, invasive mechanical ventilation, acute kidney injury, kidney replacement therapy and graft loss in the adult kidney transplant population with COVID-19.
CLINICAL CHARACTERISTICS
11/15/21
Ojha V, Mani A, Mukherjee A, et al. | Abdom Radiol
Aim: To assess the most common CT imaging features of AMI in COVID-19.
CLINICAL CHARACTERISTICS
11/15/21
Tufano A, Rendina D, Abate V, et al.  | J Clin Med
Aim: To evaluate the RD of the occurrence of VTE, pulmonary embolism (PE), and deep venous thrombosis (DVT) between COVID-19 and other pulmonary infection cohorts, in particular H1N1, and in an ICU setting. 
CLINICAL CHARACTERISTICS
11/11/21
Ramasamy C, Mishra AK, John KJ, et al. | World J Clin Cases
Aim: To identify contributors of worse outcomes in patients with malignancy and COVID-19 and to describe the role of critical care.
CLINICAL CHARACTERISTICS
11/11/21
Ahmed F, Abid M, Maniya T, et al. | Eur J Prev Cardiol
Aim: To provide a well-powered comprehensive assessment of the risk and prognosis of COVID-19 in recipients of HT.
CLINICAL CHARACTERISTICS
11/11/21
Jafar A, Lasso A, Shorr R, et al. | PLoS One
Aim: To evaluate the extent and timing of olfactory recovery following loss due to COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
11/11/21
Ulloque-Badaracco JR, Hernandez-Bustamante EA, Herrera-Añazco P, et al. | Travel Med Infect Dis
Aim: To assess the prognosis value of apolipoproteins and ApoB/ApoA1 ratio for COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
11/11/21
Mahmood MM, Jafarli I, Al-Barazanchi AF, et al. | Zhongguo Dang Dai Er Ke Za Zhi
Aim: To describe clinical features of coronavirus disease 2019 (COVID-19) in children with a focus on the possible reasons why children are less susceptible to COVID-19 and whether their immune response works better than adults.
CLINICAL CHARACTERISTICS
11/8/21
Cau A, Cheng MP, Lee T, et al. | Can J Kidney Health Dis
Aim: To review the evidence on the frequencies of AKI and renal replacement therapy (RRT) in critically ill COVID-19 patients.
CLINICAL CHARACTERISTICS
11/8/21
Ebrahimpour L, Marashi M, Zamanian H, et al. | Quant Imaging Med Surg
Aim: To compile the existing data on the CT characteristics of COVID-19 disease in children.
CLINICAL CHARACTERISTICS
11/8/21
Fakhrolmobasheri M, Mazaheri-Tehrani S, Kieliszek M, et al. | Biol Trace Elem Res
Aim: To summarize the available data surrounding the association of body selenium levels with the outcomes of COVID-19
CLINICAL CHARACTERISTICS
11/8/21
Haussner W, DeRosa AP, Haussner D, et al. | Am J Emerg Med
Aim: To conduct a systematic review of COVID-19-associated myocarditis, including clinical presentation, risk factors, and prognosis.
CLINICAL CHARACTERISTICS
11/8/21
Agyemang C, Richters A, Jolani S, et al. | BMJ Glob Health
Aim: To describe the presence and magnitude of associations between ethnic groups and COVID-19-related outcomes.
CLINICAL CHARACTERISTICS
11/8/21
Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M | Clin Environ Med
Aim: To obtain data on the status of the hemostatic factors of COVID-19.
CLINICAL CHARACTERISTICS
11/8/21
Margarucci LM, Enrico M, GIanfranceschi G, et al.  | Acta Biomed
Aim: To assess whether low serum 25-OHD is associated with susceptibility to COVID 19, their severity, and mortality. 
UPDATED
CLINICAL CHARACTERISTICS
11/5/21
Li Y, Chen B, Hong Z, et al. | Sleep Med
Aim: To review the evidence on the prevalence of insomnia symptoms during the early and late stages of the COVID-19 pandemic in China, and to determine the prevalence of insomnia symptoms in specific populations during the pandemic.
CLINICAL CHARACTERISTICS
11/5/21
Heidarpour M, Abhari AP, Sadeghpour N, et al. | Diabetes Metab Syndr
Aim: To investigate the clinical outcome of COVID-19 in patients with prediabetes
UPDATED
CLINICAL CHARACTERISTICS
11/5/21
Damara FA, Muchamad GR, Ikhsani R, et al. | Diabetes Metab Syndr
Aim: To summarize recent findings on the relationship between thyroid disease and COVID-19 outcome.
UPDATED
CLINICAL CHARACTERISTICS
11/4/21
Nikolopoulos M, Maheshwari MK, Doumouchtsis SK, et al. | Arch Gynecol Obstet
Aim: To evaluate the impact of the COVID-19 pandemic on patients with gynaecological cancer and the impact of cancer on the clinical presentation of COVID-19 infection.
CLINICAL CHARACTERISTICS
11/3/21
Alrashed F, Battat R, Abdullah I, et al. | BMJ Open Gastroenterol
Aim: To evaluate the association between IBD therapies and severe COVID-19 outcomes.
CLINICAL CHARACTERISTICS
11/3/21
Hartling L, Pillay J, Bialy L, et al. | SPOR
Aim: To review the evidence on the incidence and outcomes of myocarditis and pericarditis following COVID-18 vaccination.
CLINICAL CHARACTERISTICS
11/3/21
Hoang MP, Staibano P, McHugh T, et al. | Int Forum Allergy Rhinol
Aim: To assess the sensitivity of self-reporting and psychophysical tests for OGD.
UPDATED
CLINICAL CHARACTERISTICS
11/3/21
Lindsay RK, Wilson JJ, Trott M, et al. | Ann Med
Aim: To synthesise the recommendations for returning athletes who have experienced long COVID symptoms.
UPDATED
CLINICAL CHARACTERISTICS
11/2/21
Thakker RA, Elbadawi A, Chatila KF, et al. | Curr Probl Cardiol
Aim: To review the evidence on the presentation of STEMI patients who have SARS-CoV-2.
CLINICAL CHARACTERISTICS
11/2/21
Lee JX, Chieng WK, Lau SCD, et al. | Front Med
Aim: To provide an overview of the clinical profile, including the clinical presentations, laboratory, and radiological findings, as well as the outcome of COVID-19 infection among patients with hemoglobinopathy.
UPDATED
CLINICAL CHARACTERISTICS
11/2/21
Tripathi K, Godoy Brewer G, Thu Nguyen M, et al. | Inflamm Bowel Dis
Aim: To investigate the epidemiology, clinical characteristics, and outcomes in IBD patients with COVID-19.
CLINICAL CHARACTERISTICS
11/2/21
Funakoshi K, Morita T, Kumanogoh A | Front Med
Aim: To review the clinical course among intubated survivors, non-survivors, and extracorporeal membrane oxygenation (ECMO) patients to reveal the standard clinical course and the difference among critical COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/2/21
Li Z, Shao W, Zhang J, et al. | Front Cardiovasc Med
Aim: To clarify the prevalence and clinical impact of AF and new-onset AF in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/1/21
Bacon SL, Ribeiro PAB, Stojanovic J, et al. | SPOR
Aim: To review the evidence on how the level of vaccine effectiveness, including effectiveness against asymptomatic and symptomatic infection, and severe outcomes change over time in individuals who have received a complete primary COVID-19 vaccine series.
CLINICAL CHARACTERISTICS
11/1/21
Smith CM, Gilbert EB, Riordan PA, et al. | Gen Hosp Psychiatry
Aim: To describe the comorbidities, presentations, and outcomes of adults with incident psychosis and a history of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/1/21
Hvas CL, Larsen JB, Adelborg K, et al. | Semin Thromb Hemost
Aim: To review the evidence on dynamic hemostasis and fibrinolysis assays in intensive care in COVID-19 patients and association with thrombosis and bleeding.
CLINICAL CHARACTERISTICS
11/1/21
Poudel AN, Zhu S, Cooper N, et al. | PLoS One
Aim: To review the evidence on the impacts of COVID-19 on HRQoL of patients with Covid-19 (confirmed or suspected) and explore the risk factors for reduced HRQoL of Covid-19 patients.
CLINICAL CHARACTERISTICS
11/1/21
Vasilevska V, Guest PC, Bernstein HG, et al. | J Neuroinflammation
Aim: To identify published cases of anti-NMDAR encephalitis with concurrent neuropsychiatric symptoms temporally associated with SARS-CoV-2 infections.
CLINICAL CHARACTERISTICS
11/1/21
Hartmann-Boyce J, Rees K, Perring JC, et al. | Diabetes Care
Aim: To review the evidence regarding the extent to which PWD are at increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or of suffering its complications, including associated mortality.
WHO COLLABORATIVE
CLINICAL CHARACTERISTICS
11/1/21
Hou H, Xu J, Li Y, et al. | J Allergy Clin Immunol Pract
Aim: To investigate the association between asthma and the risk for mortality among COVID-19 patients.
CLINICAL CHARACTERISTICS
10/29/21
Chen JJ, Lee TH, Tian YC, et al. | JAMA Netw Open
Aim: To assess immunogenicity rates in people with end-stage kidney disease (ESKD) receiving SARS-CoV-2 vaccines, explore postvaccination potential risk factors for nonresponse, and assess whether receiving dialysis is associated with different antibody response rates compared with the nondialysis population.
CLINICAL CHARACTERISTICS
10/28/21
Yeahia R, Schefflein J, Chiarolanzio P, et al.  | Clin Imaging
Aim: To compile and analyze brain MRI findings in patients with COVID-19 disease and PRES.
CLINICAL CHARACTERISTICS
10/28/21
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Diabetol Metab Syndr
Aim: To re-evaluate the association of SARS-CoV-2 and development of DKA and analyse the demographic and biochemical parameters and the clinical outcomes in COVID-19 patients with DKA.
CLINICAL CHARACTERISTICS
10/28/21
Lampsas S, Tsaplaris P, Pantelidis P, et al. | Curr Med Chem
Aim: To understand the global pattern of endothelial biomarkers related to COVID-19 severity.
CLINICAL CHARACTERISTICS
10/27/21
Yasmin F, Najeeb H, Naeem A, et al. | Diseases
Aim: To report cases of COVID-19 associated mucormycosis (CAM), evaluate characteristics, clinical manifestations, and outcomes of mucormycosis in COVID-19 active or recovered patients.
CLINICAL CHARACTERISTICS
10/27/21
Hafeez MU, Ikram M, Shafiq Z, et al.  | Clin Appl Thromb Hemost
Aim: To extrapolate thrombotic risk factors, clinical manifestations, and outcomes of patients diagnosed with TTS following the COVID-19 vaccine.
CLINICAL CHARACTERISTICS
10/27/21
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al.  | BMJ Open
Aim: To investigate the association between diabetes, hypertension, body mass index (BMI) or smoking with the risk of death in patients with COVID-19 and to estimate the proportion of deaths attributable to these conditions.
UPDATED
CLINICAL CHARACTERISTICS
10/27/21
Zuin M, Rigatelli G, Bilato C, et al. | Viruses
Aim: To review the evidence on the prevalence and mortality risk in COVID-19 patients with MetS.
CLINICAL CHARACTERISTICS
10/26/21
Ponsford MJ, Ward TJC, Stoneham SM, et al. | Front Immunol
Aim: To investigate the risk of mortality and critical care admission in hospitalised adults with nosocomial COVID-19, relative to adults requiring hospitalisation due to community-acquired infection.
UPDATED
CLINICAL CHARACTERISTICS
10/26/21
van Hattum JC, Spies JL, Verwijs SM, et al. | BMJ Open Sport Exerc Med
Aim: To provide a comprehensive overview of myocardial and pericardial involvement after SARS-CoV-2 infection, long-term cardiac sequelae after infection and risks of sudden cardiac arrest/sudden cardiac death (SCA/SCD) in athletes.
UPDATED
CLINICAL CHARACTERISTICS
10/26/21
Ho QY, Sultana R, Lee TL, et al. | Singapore Med J
Aim: To examine the presenting features, outcomes and the effect of treatment on outcomes of KTRs with COVID-19. 
CLINICAL CHARACTERISTICS
10/26/21
Li W, Huang Z, Tan B, et al. | J Orthop Translat
Aim: To review the evidence on low-dosage glucocorticoid associated osteonecrosis in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/26/21
Scquizzato T, Landoni G, Scandroglio AM, et al. | Eur J Emerg Med
Aim: To assess outcomes of SARS-CoV-2 patients with out-of-hospital cardiac arrest.
UPDATED
CLINICAL CHARACTERISTICS
10/26/21
Guo T, Jiang F, Liu Y, et al. | Front Mol Biosci
Aim: To determine the respiratory outcomes in patients following COVID-19-related hospitalization.
CLINICAL CHARACTERISTICS
10/26/21
Shi Q, Wang Z, Liu J, et al. | EClinicalMedicine
Aim: To identify the predictors of unfavorable prognosis of COVID-19 in children and adolescents.
CLINICAL CHARACTERISTICS
10/26/21
Fakhruddin KS, Haiat A, Ngo HC, et al. | Acta Odontol Scand
Aim: To review the evidence of SARS-CoV-2 in the saliva of asymptomatic individuals.
CLINICAL CHARACTERISTICS
10/25/21
Ippolito M, Simone B, Filisina C, et al. | Microorganisms
Aim: To estimate the pooled occurrence of BSIs among hospitalized patients with COVID-19 and mortality of this patient population.
CLINICAL CHARACTERISTICS
10/25/21
Middleton P, Hsu C, Lythgoe MP | Hepatology
Aim: To assess the reported clinical outcomes of patients with cirrhosis who develop COVID-19 infection.
CLINICAL CHARACTERISTICS
10/25/21
Morello W, Vianello FA, Proverbio E, et al. | Pediatr Nephrol
Aim: To describe the severity of all SARS-CoV-2 infections reported in children with INS, to evaluate the risk of new onset and relapses associated with SARS-CoV-2 infection, and to draw recommendations on their management and vaccination.
CLINICAL CHARACTERISTICS
10/25/21
Mattey-Mora PP, Begle CA, Owusu CK, et al. | Rev Med Virol
Aim: To systematically assess COVID-19 patient background characteristics and pre-existing comorbidities associated with hospitalisation status. 
UPDATED
CLINICAL CHARACTERISTICS
10/25/21
Sahni S, Gupta G, Sarda R, et al. | Diabetes Metab Syndr
Aim: To highlight the impact of cardio-metabolic comorbidities on COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
10/25/21
Podury S, Srivastava S, Khan E, et al. | Brain Sci
Aim: To review the data on CNS and PNS inflammatory disorders in COVID-19 with respect to CSF, serum and neuroimaging markers.
UPDATED
CLINICAL CHARACTERISTICS
10/22/21
Yang Z, Wang X, Wan XG, et al.  | Pediatr Pulmonol
Aim: To understand the relationship between the COVID-19 pandemic and asthma outcomes.
UPDATED
CLINICAL CHARACTERISTICS
10/20/21
Ullah I, Sohail A, Shah MUFA, et al.  | Ann Med Surg
Aim: To summarize the evidence on patients diagnosed with central retinal vein occlusion (CRVO) secondary to COVID-19.
CLINICAL CHARACTERISTICS
10/20/21
Mahapure KS, Prabhune AS, Chouvhan AV | Asian J Neurosurg
Aim: To provide an overview of acute disseminating encephalomyelitis, a potential and serious complication of COVID-19.
CLINICAL CHARACTERISTICS
10/20/21
Trimboli P, Cappelli C, Croce L, et al. | Front Endocrinol
Aim: To evaluate the clinical characteristics of SAT.
CLINICAL CHARACTERISTICS
10/20/21
Miniati M, Marzetti F, Palagini L, et al. | Front Psychol
Aim: To summarize current literature studies on COVID pandemic and EDs.
CLINICAL CHARACTERISTICS
10/20/21
Yitbarek GY, Walle Ayehu G, Asnakew S, et al. | SAGE Open Med
Aim: To explore CRP in the context of COVID-19 pathogenesis and assess how its level changes with the severity of the disease.
CLINICAL CHARACTERISTICS
10/18/21
d'Ettorre G, Cacciola EG, Santinelli L, et al. | J Med Virol
Aim: To evaluate the evidence on the working capacity and the relationship life of surviving COVID-19 patients.
CLINICAL CHARACTERISTICS
10/18/21
Luo W, Liu X, Bao K, et al. | J Neurol
Aim: To explore the characteristics of ischemic stroke after SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
10/14/21
Pramana Witarto A, Samarta Witarto B, Er Putra AJ, et al. | Iran Biomed J
Aim: To assess the role of serum KL-6 in reflecting the severity of lung injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/14/21
Groff D, Sun A, Ssentongo AE, et al. | JAMA Netw Open
Aim: To estimate organ system-specific frequency and evolution of PASC.
CLINICAL CHARACTERISTICS
10/14/21
Jayant K, Reccia I, Bachul PJ, et al. | J Clin Med
Aim: To better understand the clinical course of COVID-19 in kidney transplant recipients and to identify factors associated with clinical outcomes and mortality.
UPDATED
CLINICAL CHARACTERISTICS
10/14/21
Harapan H, Fajar JK, Supriono S, et al.  | Rev Med Virol
Aim: To determine the prevalence, predictors and outcomes of ALI among patients with COVID-19.
CLINICAL CHARACTERISTICS
10/13/21
Hirschfeld AS | Neurol Neurochir Pol
Aim: To systematically review scientific reports presenting patients with hyperkinetic movement disorders as one of the neurological symptoms.
CLINICAL CHARACTERISTICS
10/13/21
Chong WH, Saha BK, Medarov BI | J Intensive Care Med
Aim: To compare the clinical characteristics between COVID-19 survivors and nonsurvivors requiring ECMO support.
UPDATED
CLINICAL CHARACTERISTICS
10/13/21
Misra S, Kolappa K, Prasad M, et al. | Neurology
Aim: To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality.
CLINICAL CHARACTERISTICS
10/13/21
Lu H, Shi Y, Chen K, et al. | J Zhejiang Univ Sci B
Aim: To provide a comprehensive perspective into the association between anticancer regimens and the outcomes of cancer patients with COVID-19.
CLINICAL CHARACTERISTICS
10/12/21
Mirmoeeni S, Azari Jafari A, Hashemi SZ, et al. | J Cardiovasc Thorac Res
Aim: To determine the rates of CVDs in COVID-19 patients based on the incidence proportion of cardiac manifestations, laboratory findings, and related comorbidities.
CLINICAL CHARACTERISTICS
10/12/21
Jiménez-Ruiz CA, López-Padilla D, Alonso-Arroyo A, et al. | Arch Bronconeumol
Aim: To review the evidence on whether tobacco use in COVID-19 patients associated with a negative progression and adverse outcome of the disease.
CLINICAL CHARACTERISTICS
10/12/21
Agouridis AP, Pagkali A, Zintzaras E, et al. | Atheroscler Plus
Aim: To systematically address all the relevant evidence of the association between high-density lipoprotein cholesterol (HDL-C) and COVID-19 infection.
CLINICAL CHARACTERISTICS
10/12/21
Sinha A, Bhaskar SMM | Int Forum Allergy Rhinol
Aim: To estimate the prevalence of mucormycosis amongst hospitalized COVID-19, and COVID-19 among hospitalized mucormycosis patients.
CLINICAL CHARACTERISTICS
10/12/21
Mahat RK, Rathore V, Singh N, et al. | Clin Nutr ESPEN
Aim: To evaluate the association of lipid parameters (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triacylglycerols) with the severity and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
10/12/21
Sandler CX, Wyller VBB, Moss-Morris R, et al. | Open Forum Infect Dis
Aim: To review the evidence on post-COVID fatigue.
CLINICAL CHARACTERISTICS
10/12/21
Udomkarnjananun S, Kerr SJ, Townamchai N, et al.  | Sci Rep
Aim: To systematically analyze published evidence for risk factors associated with mortality in COVID-19 KTR. 
CLINICAL CHARACTERISTICS
10/12/21
Renaud-Charest O, Lui LMW, Eskander S, et al. | J Psychiatr Res
Aim: To synthesize the extant evidence reporting on the frequency and factors associated with depression in post-COVID-19 syndrome.
UPDATED
CLINICAL CHARACTERISTICS
10/12/21
Jain A, Taneja S | Oral Maxillofac Surg
Aim: To collate and evaluate the data to enable clinicians to understand the disease pattern and types of mycosis and provide meticulous management of these infections in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/12/21
Soetedjo NNM, Iryaningrum MR, Damara FA, et al. | Clin Nutr ESPEN
Aim: To evaluate the prognostic properties of hypoalbuminemia for poor prognosis and factors that may influence the relationship.
UPDATED
CLINICAL CHARACTERISTICS
10/8/21
Sodeifian F, Seyedalhosseini ZS, Kian N, et al. | Front Med
Aim: To examine DILI in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/6/21
Reininghaus EZ, Manchia M, Dalkner N, et al. | Eur Neuropsychopharmacol
Aim: To elucidate the risk and treatment effect of COVID-19 in BD and research on vaccinations in individuals with BD.
CLINICAL CHARACTERISTICS
10/6/21
Farooq H, Aemaz Ur Rehman M, Asmar A, et al. | J Taibah Univ Med Sci
Aim: To recognize the novel association of IgAN and IgAV with COVID-19 and describe its underlying pathogenesis.
CLINICAL CHARACTERISTICS
10/5/21
Rahman MM, Bhattacharjee B, Farhana Z, et al. | J Prev Med Hyg
Aim: To estimate the prevalence of all reported symptoms and comorbidities, and then identified the risk factors associated with age of COVID-19 infected patients.
CLINICAL CHARACTERISTICS
10/5/21
Patel S, Parikh C, Verma D, et al. | Int J Clin Pract
Aim: To provide a holistic review of our current understanding of COVID-19 induced bowel ischemia.
CLINICAL CHARACTERISTICS
10/5/21
Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, et al. | J Prev Med Hyg
Aim: To assess the pooled CFR of COVID-19.
CLINICAL CHARACTERISTICS
10/5/21
Kan C, Zhang Y, Han F, et al. | Front Endocrinol
Aim: To assess various antidiabetic agents’ association with mortality in patients with type 2 diabetes (T2DM) who have coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
10/5/21
Yin Y, Rohli KE, Shen P, et al. | Prim Care Diabetes
Aim: To summarize epidemiologic evidence of COVID-19 in patients with Type 2 diabetes, explore pathophysiological mechanisms, and integrate recommendations and guidelines for patient management.
CLINICAL CHARACTERISTICS
10/4/21
Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, et al.  | J Clin Neurol
Aim: To describe the clinical features of MFS in patients with COVID-19.
CLINICAL CHARACTERISTICS
10/4/21
Wilairatana P, Masangkay FR, Kotepui KU, et al. | PLoS Negl Trop Dis
Aim: To synthesize, qualitatively and quantitatively, information on the prevalence and characteristics of malaria infection among COVID-19-infected individuals. 
UPDATED
CLINICAL CHARACTERISTICS
10/1/21
Mehraeen E, Oliaei S, SeyedAlinaghi S, et al. | Infect Disord Drug Targets
Aim: To reflect on the current knowledge and practice of COVID-19 among children.
CLINICAL CHARACTERISTICS
10/1/21
Teo KY, Invernizzi A, Staurenghi G, et al. | Am J Ophthalmol
Aim: To evaluate the occurrence of retinal micro-vasculopathy in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and developed coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
10/1/21
Sahebi A, Abdi K, Moayedi S, et al. | J Psychosom Res
Aim: To estimate the prevalence of insomnia in healthcare workers.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Singh P, Singh SP, Verma AK, et al. | Visc Med
Aim: To evaluate key imaging manifestations of COVID-19 on abdominal imaging.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Shah VP, Farah WH, Hill JC, et al.  | Open Forum Infect Dis
Aim: To assess the association between CT values and clinical outcomes, including the risk of hospitalization among patients with COVID-19 and the risk of disease severity and death in such patients.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Michelen M, Manoharan L, Elkheir N, et al. | BMJ Glob Health
Aim: To regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes.
CLINICAL CHARACTERISTICS
9/30/21
Jain S, Khanna P, Sarkar S | Monaldi Arch Chest Dis
Aim: To identify the overall incidence of VAP, common organisms associated with it, and outcome in COVID-19 patients in comparison to the non-SARS-CoV-2 infected critically ill ventilated COVID-19 patients. 
CLINICAL CHARACTERISTICS
9/30/21
Attisani L, Pucci A, Luoni G, et al.  | J Cardiovasc Surg
Aim: To analyze the outcomes of acute limb ischemia (ALI) in patients suffering from the novel Coronavirus COVID-19 (Sars-Cov-2).
CLINICAL CHARACTERISTICS
9/30/21
Bissacco D, Lomazzi C, Buongiovanni G, et al. | J Cardiovasc Surg
Aim: To present evidence published on COVID-19 and aortic-related issues, highlighting some challenging aspects regarding management, treatment and outcomes.
CLINICAL CHARACTERISTICS
9/30/21
Aggarwal AN, Agarwal R, Dhooria S, et al. | Respir Care
Aim: To evaluate whether asthma increases the risk of severe disease and adverse outcomes among subjects with COVID-19.
CLINICAL CHARACTERISTICS
9/30/21
Zhou C, Zhao Y, Wang X, et al. | Pediatr Pulmonol
Aim: To characterize the laboratory parameters of MIS-C compared with those of KD and Kawasaki disease shock syndrome (KDSS).
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Maiese A, Frati P, Del Duca F, et al. | Diagnostics
Aim: To evaluate the current knowledge about postmortem cardiac findings in patients who died of COVID-19.
CLINICAL CHARACTERISTICS
9/30/21
Musa SS, Bello UM, Zhao S, et al. | Viruses
Aim: To summarize the evidence from existing systematic reviews about the effects of SARS-CoV-2 infections on maternal perinatal and neonatal outcomes.
CLINICAL CHARACTERISTICS
9/28/21
Chong WH, Saha BK, Neu KP | Infection
Aim: To assess the clinical characteristics and outcomes of patients diagnosed with CAPA compared to those without CAPA.
UPDATED
CLINICAL CHARACTERISTICS
9/28/21
Sakthiswary R, Chuah HY, Chiang KS, et al. | Lupus
Aim: To determine the predictors of severe COVID-19 infection in SLE by comparing the mild to moderate cases with the severe to critical ones.
CLINICAL CHARACTERISTICS
9/28/21
Santos RPD, Lordani TVA, Peres LAB, et al. | Nefrologia
Aim: To determine the AKI incidence in patients hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
9/27/21
Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, et al. | BMJ
Aim: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19).
CLINICAL CHARACTERISTICS
9/27/21
Bahrami R, Schwartz DA, Karimi-Zarchi M, et al.  | Turk J Obstet Gynecol
Aim: To estimate the frequency of intrauterine growth restriction (IUGR) and preterm premature rupture of the membranes (PPROM) in pregnant women with Coronavirus disease-2019 (COVID-19).
CLINICAL CHARACTERISTICS
9/27/21
Pizzol D, Shin JI, Trott M, et al.  | J Endocrinol Invest
Aim: To calculate the pooled prevalence of ED amongst healthcare workers.
CLINICAL CHARACTERISTICS
9/27/21
Fernández-de-Las-Peñas C, Navarro-Santana M, Plaza-Manzano G, et al. | Pain
Aim: To synthesize the prevalence of post-COVID pain symptoms of musculoskeletal origin in hospitalized/non-hospitalized patients recovered from SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
9/24/21
Whear R, Abbott RA, Bethel A, et al. | J Adv Nurs
Aim: To review the evidence on the provision of fundamental nursing care to hospitalized patients with a highly infectious virus and the effectiveness of adaptations to overcome barriers to care.
UPDATED
CLINICAL CHARACTERISTICS
9/24/21
Quante M, Brake L, Tolios A, et al. | Transplant Proc
Aim: To produce a current synoptic assessment of mortality and clinical outcomes subsequent to infection and COVID-19 in SOT recipients.
CLINICAL CHARACTERISTICS
9/24/21
Sengupta P, Leisegang K, Agarwal A | Arab J Urol
Aim: To provide a concise update on the effects of coronavirus disease 2019 (COVID-19) on male reproduction.
CLINICAL CHARACTERISTICS
9/23/21
Keshavarz P, Haseli S, Yazdanpanah F, et al. | Acad Radiol
Aim: To categorize and summarize the imaging data in COVID-19-induced anosmia.
CLINICAL CHARACTERISTICS
9/23/21
Patel P, DeCuir J, Abrams J, et al. | JAMA Netw Open
Aim: To summarize the descriptive epidemiology and clinical characteristics of MIS-A.
CLINICAL CHARACTERISTICS
9/23/21
Erbas GS, Botsali A, Erden N, et al. | Int J Dermatol
Aim: To review the evidence on specific manifestations of COVID-19 in the oral mucosa.
CLINICAL CHARACTERISTICS
9/23/21
Srivastava R, Parveen R, Mishra P, et al. | Int J Clin Pract
Aim: To assess the association of venous thromboembolism with severity of COVID-19 disease.
CLINICAL CHARACTERISTICS
9/22/21
Lashkari A, Ranjbar R | J Neurovirol
Aim: To review the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis. 
CLINICAL CHARACTERISTICS
9/22/21
Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the prevalence of COVID-19 (diagnosed using PCR and/or serology) in patients with CLL.
UPDATED
CLINICAL CHARACTERISTICS
9/22/21
Wiedenmann M, Goutaki M, Keiser O, et al. | Swiss Med Wkly
Aim: To review the evidence on the role of children and adolescents in the SARS-CoV-2 pandemic, specifically the severity of SARS-CoV-2 presentation, risk of SARS-CoV-2 infection and risk of transmitting SARS-CoV-2.
CLINICAL CHARACTERISTICS
9/21/21
Hossein Kazemi M, Kuhestani Dehaghi B, et al. | Iran J Med Sci
Aim: To explore the possible association of HScore parameters with severity in COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
9/21/21
Geng J, Yu X, Bao H, et al. | Front Med
Aim: To determine the predictive value of chronic diseases for the severity and mortality of COVID-19.
CLINICAL CHARACTERISTICS
9/21/21
Long Q, Li J, Hu X, et al. | Front Med
Aim: To determine the adverse effects on multiple systems and differences between severe and non-severe patients in the post-acute phase.
UPDATED
CLINICAL CHARACTERISTICS
9/20/21
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian A | Clin Cardiol
Aim: To review the evidence on the prognostic utility of right ventricular dysfunction (RVD) in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
9/20/21
Zamani R, Pouremamali R, Rezaei N | Rev Neurosci
Aim: To determine the profile and possible mechanisms behind CNS inflammatory diseases in the context of Covid-19.
CLINICAL CHARACTERISTICS
9/20/21
von Bartheld CS, Hagen MM, Butowt R | ACS Chem Neurosci
Aim: To review the evidence on the role of COVID-19 and genetics on the presentation of anosmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/20/21
Alemzadeh E, Alemzadeh E, Ziaee M, et al. | Immun Inflamm Dis
Aim: To analyze the correlation between admission to ICU and hospital, disease severity, mortality, D-dimer count, lymphocyte count, and serum calcium levels.
CLINICAL CHARACTERISTICS
9/16/21
Ghayda RA, Lee KH, Kim JS, et al. | Int J Med Sci
Aim: To document the chest CT findings in patients with confirmed COVID-19 and their association with the clinical severity.
CLINICAL CHARACTERISTICS
9/16/21
Martins LA, Santos DVD, Marques PF, et al. | Rev Gaucha Enferm
Aim: To identify in the scientific literature the clinical overview of the pediatric population that tested positive for SARS-CoV-2 and care recommendations and recommendations among children who tested positive for SARS-CoV-2. 
CLINICAL CHARACTERISTICS
9/15/21
Mazzaccaro D, Giannetta M, Fancoli F, et al. | J Cardiovasc Surg
Aim: To review the prevalence, the risk factors and the outcomes of venous thrombosis (VT) in patients hospitalized for COronaVirus Disease 19 (COVID-19).
CLINICAL CHARACTERISTICS
9/15/21
Ming W, Zuo J, Han J, et al. | Eur Arch Otorhinolaryngol
Aim: To analyze the impact of AAD on the severity and mortality of COVID-19 patients and compare clinical outcomes between patients with and without AAD.
UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Marasco G, Maida M, Morreale GC, et al. | Can J Gastroenterol Hepatol
Aim: To estimate the rate of gastrointestinal bleeding in COVID-19 patients and its association with mortality.
CLINICAL CHARACTERISTICS
9/14/21
Liu L, Ni SY, Yan W, et al. | EClinicalMedicine
Aim: To assess the overall and type-specific risk of mental and neurological disorders for COVID-19 infection and clinical outcomes. 
UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Aragoneses J, Suárez A, Algar J, et al. | Front Med
Aim: To investigate the types of oral manifestations of COVID-19 and their prevalence.
CLINICAL CHARACTERISTICS
9/13/21
Becchetti C, Gschwend SG, Dufour JF, et al. | J Clin Med
Aim: To analyze and summarize the published literature concerning LT recipients with COVID-19.
CLINICAL CHARACTERISTICS
9/13/21
Prakash J, Bhattacharya PK, Yadav AK, et al. | J Crit Care
Aim: To determine the predictive accuracy of the ROX index for predicting HFNC failure in COVID-19 patients with AHRF.
UPDATED
CLINICAL CHARACTERISTICS
9/13/21
de Freitas RF, Torres SC, Martín-Sánchez FJ, et al. | Auton Neurosci
Aim: To systematically review the recent published literature that describes syncope or presyncope as a symptom of COVID-19, having it been observed in the days before or after the diagnosis.
CLINICAL CHARACTERISTICS
9/10/21
Saniasiaya J, Kulasegarah J, Narayanan P | J Laryngol Otol
Aim: To elucidate olfactory dysfunction amongst children and adolescents with coronavirus disease 2019.
CLINICAL CHARACTERISTICS
9/9/21
Zinellu A, Paliogiannis P, Fois AG, et al. | Front Public Health
Aim: To capture and interpret the available evidence regarding the relationship between COVID-19 and lipid profile.
UPDATED
CLINICAL CHARACTERISTICS
9/9/21
Corica B, Marra AM, Basili S, et al. | Sci Rep
Aim: To evaluate the prevalence of RVD and associated outcomes in patients with COVID-19
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | Intern Med J
Aim: To investigate the incidence, characteristics, and outcomes of patients who were readmitted to hospital emergency departments or required re-hospitalization following an index hospitalization with a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Nayeri ND, Nadali J, Divani A, et al. | J Res Med Sci
Aim: To systematically review of symptoms, laboratory and radiologic findings, treatment, and outcomes of patients with COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Shams Vahdati S, Ala A, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To systematically review the previous systematic reviews which addressed the neurological manifestations of the COVID-19 infection.
CLINICAL CHARACTERISTICS
9/8/21
Tan X, Guo J, Chen Z, et al. | Therap Adv Gastroenterol
Aim: To report on clinical outcomes of COVID-19 patients who underwent GI endoscopy.
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Malekifar P, Pakzad R, Shahbahrami R, et al. | Biomed Res Int
Aim: To identify the viral coinfection prevalence among infected people with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Sari Motlagh R, Abufaraj M, Karakiewicz PI, et al.  | World J Urol
Aim: To assess the risk of SARS-CoV-2 infection and the severity of disease in PCa patients treated with ADT. 
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Minh LHN, Abozaid AA, Ha NX, et al. | Rev Med Virol
Aim: To estimate the frequency of clinical symptoms by comparing different clinical presentations based on the severity and living status of the cases.
CLINICAL CHARACTERISTICS
9/7/21
Kim JY, Han K, Suh YJ | J Cardiovasc Magn Reson
Aim: To investigate the prevalence of abnormal CMR findings in recovered COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
9/3/21
Mutneja HR, Bhurwal A, Arora S, et al. | Scand J Gastroenterol
Aim: To evaluate whether COVID-19 affects the severity and outcomes associated with acute pancreatitis.
CLINICAL CHARACTERISTICS
9/1/21
Spacey A, Porter S, Board M, et al. | Palliat Med
Aim: To describe and evaluate the impact of the COVID-19 pandemic on end of life care delivery in care homes.
CLINICAL CHARACTERISTICS
9/1/21
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS) and conduct meta-regression to evaluate effects of persistent symptoms and ICU admission on poor quality of life.
CLINICAL CHARACTERISTICS
8/31/21
Wang Y, Wang Y, Huo L, et al. | J Neurol
Aim: To review the evidence on the acute and post-infectious manifestations of SARS-CoV-2-associated ADEM to guide long-term management and health service reorganization.
CLINICAL CHARACTERISTICS
8/30/21
Kornitzer J, Johnson J, Yang M, et al. | Int J Environ Res Public Health
Aim: To assess the spectrum of COVID-19 presentation in children, with special emphasis on characteristics associated with multisystem inflammatory syndrome (MIS-C). 
CLINICAL CHARACTERISTICS
8/30/21
O'Loughlin L, Alvarez Toledo N, Budrie L, et al. | Neurol Int
Aim: To provide an updated review of the current published data on pediatric patients with COVID-19 and coexisting severe neurological manifestations.
CLINICAL CHARACTERISTICS
8/30/21
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize the clinical features of ADEM and AHLE, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
8/30/21
Aram K, Patil A, Goldust M, et al. | Dermatol Ther
Aim: To evaluate presentations, post-infection change in the manifestation, diagnosis, and management of flare-ups of underlying dermatologic disease in patients with COVID-19. 
CLINICAL CHARACTERISTICS
8/30/21
Sanchez-Ramirez DC, Normand K, Zhaoyun Y, et al. | Biomedicines
Aim: To explore persistent effects of COVID-19 beyond 3 months follow-up on patient chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, quality of life, and the ability to return to work. 
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Treskova-Schwarzbach M, Haas L, Reda S, et al. | BMC Med
Aim: To summarise the evidence on age-adjusted associations between multiple pre-existing health conditions and clearly defined COVID-19 outcomes separating the effects between the geographical regions.
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Rathore SS, Hussain N, Manju AH, et al. | J Med Virol
Aim: To evaluate the correlation between COVID-19 disease and pleural effusion.
CLINICAL CHARACTERISTICS
8/30/21
Treglia G, Cuzzocrea M, Giovanella L, et al. | Pharmaceuticals
Aim: To calculate the prevalence of hypermetabolic lymph nodes after COVID-19 infection.
CLINICAL CHARACTERISTICS
8/27/21
Ousseiran ZH, Fares Y, Chamoun WT | Int J Neurosci
Aim: To study and summarize the different neurological manifestations of this virus.
CLINICAL CHARACTERISTICS
8/27/21
Sarkar S, Kannan S, Khanna P, et al  | J Med Virol
Aim: To explore the utility of PLR as a prognostic predictor of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/26/21
Qian W, Ye Y, Zuo L, et al. | Immunotherapy
Aim: To quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
8/26/21
Saniasiaya J, Prepageran N | J Laryngol Otol
Aim: To outline the impact on quality of life in coronavirus disease 2019 patients with olfactory dysfunction.
CLINICAL CHARACTERISTICS
8/26/21
Kyiakoulis KG, Kollias A, Kyrakoulis IG, et al. | Curr Vasc Pharmacol
Aim: To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge).
CLINICAL CHARACTERISTICS
8/23/21
Sullivan BN, Fischer T | Front Aging Neurosci
Aim: To gain insight into the types of neurological complications associated with SARS-CoV-2 infection and their possible relationship with age, sex, COVID-19 severity, and comorbidities.
CLINICAL CHARACTERISTICS
8/23/21
An W, Kang J, Wang Q, et al. | J Infect Public Health
Aim: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
8/23/21
Ghorbani SS, Taherpour N, Bayat S, et al. | J Med Virol
Aim: To review the evidence on the frequency and definitions of re-infection rates, recurrence, and hospital readmission following SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/23/21
Yan Q, Qiu D, Liu X, et al. | Front Pediatr
Aim: To examine the pooled prevalence of smell or taste dysfunctions among children with COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Bhattacharyya A, Sarma P, Sharma DJ, et al. | Indian J Pharmacol
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
8/23/21
Mashayekhi F, Sairafianpour F, Mohammad AP, et al. | Int J Clin Pract
Aim: To review the evidence on presentations of severe potential life-threatening skin eruptions in COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Han T, Ma S, Sun C, et al. | Arch Med Res
Aim: To further explore queries about effects of anti-diabetic agents on mortality and poor composite outcomes of COVID-19 in diabetic patients.
CLINICAL CHARACTERISTICS
8/17/21
Finsterer J, Scorza FA, Scorza C, et al. | Bosn J Basic Med Sci
Aim: To summarize and discuss the recent advances concerning the clinical presentation, pathophysiology, diagnosis, treatment, and outcomes of SARS-CoV-2 associated cranial nerve mononeuropathies or polyneuropathies. 
CLINICAL CHARACTERISTICS
8/16/21
Ismail II, Salama S | J Neurol
Aim: To investigate the available evidence regarding the different types of CNS demyelination in association with SARS-CoV-2 infection, and the proposed pathophysiological mechanisms in these cases.
CLINICAL CHARACTERISTICS
8/16/21
Sunjaya AP, Allida SM, Di Tanna GL, et al. | Eur Respir J
Aim: To review the evidence on whether people with asthma at a higher risk of being infected, hospitalised or of poorer clinical outcomes from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/16/21
Karaoulanis SE, Christodoulou NG | Psychiatriki
Aim: To clarify whether patients with schizophrenia spectrum disorders are at greater risk for poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
8/16/21
Alsagaff MY, Oktaviono YH, Dharmadjati BB, et al.  | J Arrythm
Aim: To evaluate the latest evidence on the association of ECG on admission and the poor outcomes in COVID?19.
CLINICAL CHARACTERISTICS
8/16/21
Maiese A, Manetti AC, Bosetti C, et al. | Brain Pathol
Aim: To review the evidence on the neuropathological features of COVID-19.
CLINICAL CHARACTERISTICS
8/16/21
Patanavanich R, Glantz SA  | BMC Public Health
Aim: To compare the association between smoking and COVID-19 disease progression between unadjusted analyses with adjusted analyses to examine whether smoking is an independent risk factor.
CLINICAL CHARACTERISTICS
8/16/21
Abate V, Casoria A, Rendina D, et al. | Semin Thromb Hemost
Aim: To describe the prevalence and the clinical characteristics of SMH in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/13/21
Kazemi SN, Hajikhani B, Didar H, et al. | PLoS One
Aim: To understand better the potential effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on fetal loss in infected mothers presented with abortion following this infection.
CLINICAL CHARACTERISTICS
8/13/21
AbdelHamid S, Refaat AA, Benjamin AM, et al. | Environ Sci Pollut Res Int
Aim: To study the impact of host or viral epigenetic modulation on COVID-19 infection susceptibility and/or outcome.
UPDATED
CLINICAL CHARACTERISTICS
8/13/21
Llamas M, Garo ML, Giovanella L | Clin Chem Lab Med
Aim: To assess the prognostic role of fT3 serum levels in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/12/21
Sah P, Fitzpatrick MC, Zimmer CF, et al. | Proc Natl Acad Sci USA
Aim: To review the evidence on laboratory-confirmed infections to estimate the percentage of SARS-CoV-2 infections that are truly asymptomatic. 
CLINICAL CHARACTERISTICS
8/12/21
Huth SF, Cho S, Robba C, et al. | Front Neurol
Aim: To review the evidence on the neurologic manifestations identified in hospitalised COVID-19 patients and provide a preliminary estimate of disease prevalence.
CLINICAL CHARACTERISTICS
8/12/21
Sen S, Kanna NB, Kumar J, et al. | Int Ophthalmol
Aim: To summarize all retinal manifestations secondary to COVID-19 disease recorded till date since the beginning of the pandemic.
CLINICAL CHARACTERISTICS
8/11/21
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | Sci Rep
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage.
UPDATED
CLINICAL CHARACTERISTICS
8/10/21
Chung EY, Palmer SC, Natale P, et al. | Am J Kidney Dis
Aim: To assess the incidence and outcomes of COVID-19 in people with CKD.
CLINICAL CHARACTERISTICS
8/10/21
Yang Y, Cai Z, Zhang J | Front Endocrinol
Aim: To determine the association between insulin injection and the outcomes of COVID-19.
CLINICAL CHARACTERISTICS
8/10/21
Qian Z, Lu S, Luo X, et al. | Front Med
Aim: To summarize the current existing evidence on the outcome of critically ill patients with COVID-19 as well as to evaluate the effectiveness of clinical interventions.
CLINICAL CHARACTERISTICS
8/9/21
Athanasios A, Daley I, Patel A, et al. | Eur Neurol
Aim: To review the prevalence of cerebrovascular accident in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Alves VP, Casemiro FG, Araujo BG, et al. | Int J Environ Res Public Health
Aim: To evaluate the factors associated with mortality of elderly Brazilians and Italians diagnosed with the new coronavirus who resided in institutions or who were hospitalized as a result of the disease.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Gómez CA, Sun CK, Tsai IT, et al. | Sci Rep
Aim: To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the therapeutic benefit of anticoagulant prophylaxis.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Cabreira V, Abreu P, Soares-Dos-Reis R, et al. | Vaccines
Aim: To review the evidence on the incidence and outcomes of COVID-19 in MS patients on DMTs.
CLINICAL CHARACTERISTICS
8/9/21
Ho TC, Chang CC, Chan HP, et al. | Pathogens
Aim: To analyze the pulmonary findings of [18F]FDG PET/CT on asymptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Sadiq Z, Rana S, Mahfoud Z, et al. | Clin Imaging
Aim: To determine the most common appearances of lung abnormalities in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Prada L, Santos CD, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
UPDATED
CLINICAL CHARACTERISTICS
8/7/21
Probst LF, Guerrero ATG, de Queiroz Cardoso AI, et al. | Syst Rev
Aim: To analyze the effectiveness of decontamination methods for mask reuse. 
CLINICAL CHARACTERISTICS
8/5/21
Zhang Z, Ai G, Chen L, et al. | BMC Infect Dis
Aim: To explore the association of immunological features with COVID-19 severity.
CLINICAL CHARACTERISTICS
8/4/21
Tsheten T, Clements ACA, Gray DJ, et al. | BMC Infect Dis
Aim: To collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection.
CLINICAL CHARACTERISTICS
8/4/21
Vitalakumar D, Sharma A, Kumar A, et al. | ACS Chem Neurosci
Aim: To conduct a meta-analysis of clinical studies associated with neurological problems in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/4/21
Cosentino G, Todisco M, Hota N, et al. | Eur J Neurol
Aim: To review the evidence on neuropathological findings and their clinical correlations in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Yadav AK, Ghosh S, Dubey S | Med J Armed Forces India
Aim: To summarize and synthesize evidence from all available case series and case reports published on re-positive COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
8/3/21
Wang JG, Zhong ZJ, Li M, et al. | Biochem Res Int
Aim: To describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.
CLINICAL CHARACTERISTICS
8/3/21
Taheri Soodejani M, Basti M, Tabatabaei SM, et al. | Int J Mol Epidemiol Genet
Aim: To investigate published literature about the association between measles, mumps, and rubella (MMR) vaccine and COVID-19. 
CLINICAL CHARACTERISTICS
8/3/21
Moore N, Bosco-Levy P, Thurin N, et al. | Drug Saf
Aim: To collate the evidence regarding the possible risks associated with the use of NSAIDs in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Ferreira de Araújo JL, Menezes D, Saraiva-Duarte JM, et al. | Rev Med Virol
Aim: To review genetic association studies evaluating Covid-19 severity or susceptibility to SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/3/21
Wu D, Wang VY, Chen YH, et al. | Auris Nasus Larynx
Aim: To determine how initial symptoms of OGD can be used to screen patients for COVID-19 laboratory testing.
CLINICAL CHARACTERISTICS
8/2/21
Katzenschlager S, Zimmer AJ, Gottschalk C, et al. | PLoS One
Aim: To assess demographic, laboratory and clinical indicators as predictors for severe courses of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
Ansari Ramandi MM, Yarmohammadi H, Beikmohammadi S, et al. | J Cardiovasc Thorac Res
Aim: To gather all possible cardiovascular manifestations of the coronavirus family in the literature. 
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
SeyedAlinaghi S, Karimi A, MohsseniPour M, et al.  | Immun Inflamm Dis
Aim: To investigate the impact of COVID-19 on patients infected with HIV.
CLINICAL CHARACTERISTICS
8/1/21
Kow CS, Hasan SS | Therapie
Aim: To summarize the overall effect of DPP-4 inhibitors on the clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/29/21
Ceban F, Nogo D, Carvalho IP, et al. | JAMA Psychiatry
Aim: To assess whether preexisting mood disorders are associated with a higher risk of COVID-19 susceptibility, hospitalization, severe complications, and death.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Zinellu A, Paliogiannis P, Carru C, et al. | Adv Med Sci
Aim: To review the evidence on the international normalized ratio (INR) in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Shenoy S | World J Crit Care Med
Aim: To identify whether quantitative SARS-CoV-2 viral load assay correlates with clinical outcome in COVID-19 infections.
CLINICAL CHARACTERISTICS
7/28/21
Zhu Y, Xing W, Wang H, et al. | Infect Dis
Aim: To analyze the differences of the baseline characteristics and therapeutic features between STEMI patients admitted before and after the start of the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
7/28/21
Azab MA, Hasaneen SF, Hanifa H, et al. | Interdiscip Neurosurg
Aim: To report a case manifested as post-COVID-19 optic neuritis, in addition to make a quantitative analysis (meta-analysis) for the published similar case reports around the world.
CLINICAL CHARACTERISTICS
7/28/21
Alanazi T, Alahmari N, Qubays F, et al. | J Pharmaceut Res Int
Aim: To investigate the published literature of OP related to COVID-19, estimates the prevalence of OP among COVID-19 patients, and assesses the risk or COVID-19 severity associated with OP.
CLINICAL CHARACTERISTICS
7/27/21
Goswami J, MacArthur TA, Sridharan M, et al. | Shock
Aim: To summarize and discuss the current literature on laboratory coagulation disruptions associated with COVID-19 and the clinical effects of thromboembolic events in COVID-19. 
CLINICAL CHARACTERISTICS
7/27/21
Szarpak L, Rafique Z, Gasecka A, et al. | Cardiol J
Aim: To establish a connection between vitamin D status and COVID-19 infection.
CLINICAL CHARACTERISTICS
7/27/21
Zhao R, Su Z, Komissarov AA, et al. | Front Immunol
Aim: To explore the relationships between the plasma D-dimer level on admission with demographics, laboratory tests, fatal cardiopulmonary function, radiology, interventions, complications, and outcomes.
CLINICAL CHARACTERISTICS
7/27/21
Shafiabadi Hassani N, Talakoob H, Karim H, et al. | J Magn Reson Imaging
Aim: To systematically review the main cardiac MRI findings in COVID-19 adult survivors.
CLINICAL CHARACTERISTICS
7/27/21
Rastogi A, Dogra H, Jude EB, et al. | Diabetes Metab Syndr
Aim: To identify the prevalence, risk factors and outcomes of lower extremity ischemic complications.
CLINICAL CHARACTERISTICS
7/27/21
Zahedi M, Yousefi M, Abounoori M, et al. | Iran J Med Sci
Aim: To establish the characteristics of liver function tests in COVID-19 patients.
CLINICAL CHARACTERISTICS
7/27/21
Zhang K, Zhang X, Ding W, et al. | Front Med
Aim: To evaluate the prognostic accuracy of the NEWS2 on predicting clinical deterioration for patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Karimi A, Nowroozi A, Alilou S, et al. | Urol J
Aim: To study the effect of androgen deprivation therapy (ADT) on COVID-19 in patients with prostate cancer.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Upadhyaya M, Kandre Y, et al. | QJM
Aim: To provide comprehensive overview of epidemiological, clinical and biomarker profile of COVID-19 infection in pediatric population.
CLINICAL CHARACTERISTICS
7/26/21
Purja S, Shin H, Lee JY, et al. | Arch Pharm Res
Aim: To examine the association between COVID-19 severity and loss of smell (LOS) in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Varna PV, Pandya A, et al. | QJM
Aim: To study the relationship between vitamin D level, risk and severity of COVID-19 infection in pediatric population through systematic review.
CLINICAL CHARACTERISTICS
7/26/21
Conde-Agudelo A, Romero R | Am J Obstet Gynecol
Aim: To examine the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and the risk of preeclampsia.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Ferro A, Kotecha S, Auzinger G, et al. | Br J Oral Maxillofac Surg
Aim: To determine the cumulative incidence of complications, mortality, time to decannulation and ventilatory weaning.
CLINICAL CHARACTERISTICS
7/26/21
Zaffanello M, Piacentini G, Nosetti L, et al. | Thromb Res
Aim: To review the literature for thrombotic complications in children with COVID-19 infection and MIS-C.
CLINICAL CHARACTERISTICS
7/24/21
Bou-Karroum L, Khabsa J, Jabbour M, et al. | J Infect
Aim: To map travel policies implemented due to COVID-19 during 2020.
CLINICAL CHARACTERISTICS
7/23/21
Ghidini S, Gasperetti A, Winterton D, et al. | Int J Cardiovasc Imaging
Aim: To summarize current knowledge on TTE-based RV assessment in COVID-19.
CLINICAL CHARACTERISTICS
7/23/21
Moradi G, Gholami F, Rasouli MA, et al. | Med J Islam Repub Iran
Aim: To determine possible scenarios of Coronavirus 2019 (COVID-19) iceberg using published articles.
CLINICAL CHARACTERISTICS
7/22/21
McGrowder DA, Miller F, Cross MA, et al. | Diseases
Aim: To review the evidence on abnormal liver biochemistry tests in COVID-19 and the possible pathogenesis involved.
UPDATED
CLINICAL CHARACTERISTICS
7/22/21
Zhang D, Huang WJ, Lan MQ | Eur Rev Med Pharmacol Sci
Aim: To systematically review the role of SAA levels in distinguishing among patients with mild, severe, and critical COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Dioguardi M, Cazzolla AP, Arena C, et al. | Pediatr Rep
Aim: To summarize aspects of innate immunity by focusing on the role of ACE2 expression and viral infections in children in modulating the antibody response to SARS-CoV-2 infection. 
CLINICAL CHARACTERISTICS
7/22/21
Ganesh A, Reis IR, Varma M, et al. | Can J Neurol Sci
Aim: To review the evidence on the various neurological and atypical HEENT manifestations of COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Zuin M, Gentili V, Cervellati C, et al. | Infect Dis Rep
Aim: To investigate the possible difference in the SARS-CoV-2 viral load between asymptomatic and symptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
7/20/21
Gupta S, Jawanda MK, Taneja N, et al. | J Clin Neurosci
Aim: To evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation, and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
7/20/21
Kulkarni AV, Tevethia HV, Premkumar M, et al. | EClinicalMedicine
Aim: To analyse the outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients.
CLINICAL CHARACTERISTICS
7/20/21
Vai B, Mazza MG, Delli Colli C, et al. | Lancet Psychiatry
Aim: To assess the specific risks of COVID-19-related mortality, hospitalisation, and intensive care unit (ICU) admission associated with any pre-existing mental disorder, and specific diagnostic categories of mental disorders, and exposure to psychopharmacological drug classes.
UPDATED
CLINICAL CHARACTERISTICS
7/20/21
Cirillo N | J Infect Public Health
Aim: To facilitate a timely understanding of the differences in the prevalence of gustatory disturbances (GD) in individuals infected with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Andrianto, Al-Farabi MJ, Nugraha RA, et al. | Microvasc Res
Aim: To assess biomarkers of endothelial cells in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Rashedi S, Keykhaei M, Pazoki M, et al. | Nutr Clin Pract
Aim: To ascertain risk indicators of in-hospital mortality and severity as well as to provide a comprehensive systematic review and meta-analysis to investigate the prognostic significance of the prognostic nutrition index (PNI) as a predictor of adverse outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
7/19/21
Maddaloni E, D'Onofrio L, Siena A, et al. | Intern Emerg Med
Aim: To clarify the association of cardiovascular disease with Covid-19 outcomes.
CLINICAL CHARACTERISTICS
7/19/21
Kim PH, Kim M, Suh CH, et al. | Korean J Radiol
Aim: To evaluate the incidence of radiologically demonstrated neurologic complications and detailed neuroimaging findings associated with COVID-19.
CLINICAL CHARACTERISTICS
7/19/21
van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. | Fam Pract
Aim: To create an overview of the nature and frequency of persistent symptoms experienced by patients after mild COVID-19 infection.
CLINICAL CHARACTERISTICS
7/16/21
Yilma M, Taye G, Kifle A, et al. | Ethopian Journal of Health Development
Aim: To get cohesive understanding on hospitalization, recovery, death, incubation period and severity of COVID-19.
CLINICAL CHARACTERISTICS
7/16/21
Iwamura APD, Tavares da Silva MR, Hümmelgen AL, et al.  | Rev Med Virol
Aim: To collate and critically appraise the literature relating to the inflammatory and immunological parameters of the SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/16/21
El-Qushayri AE, Ghozy S, Reda A, et al. | Rev Med Virol
Aim: To review the impact of PD on the prognosis of Covid-19 patients.
CLINICAL CHARACTERISTICS
7/15/21
Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. | Crit Care Med
Aim: To describe the prevalence of coronavirus disease 2019-related sepsis.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Saragih ID, Advani S, Saragih IS, et al. | Geriatr Nurs
Aim: To study the impacts of frailty on COVID-19 outcomes.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Mir A, Farmanfarma KK, Salehiniya H, et al. | Monaldi Arch Chest Dis
Aim: To investigate laboratory and demographic findings among patients with COVID-19 worldwide.
CLINICAL CHARACTERISTICS
7/15/21
de Medeiros KS, da Silva LAS, de Araujo Macedo LT, et al. | Rev Assoc Med Bras
Aim: To study the clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection.
CLINICAL CHARACTERISTICS
7/15/21
Yetmar Z, Chesdachai S, Kashour T, et al. | Open Forum Infect Dis
Aim: To examine the association between prior statin use and outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/14/21
Yassin A, Ghzawi A, Al-Mistarehi AH, et al. | Future Sci OA
Aim: To describe the mortality difference between acute ischemic stroke (AIS) and non-AIS groups within COVID-19 patients.
CLINICAL CHARACTERISTICS
7/13/21
Nasa P, Juneja D, Jain R, et al. | Asian Cardiovasc Thorac Ann
Aim: To analyse the types of air leaks in COVID-19 and their outcomes.
CLINICAL CHARACTERISTICS
7/13/21
Wu X, Xu Y, Jin L, et al. | Front Med
Aim: To investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function.
CLINICAL CHARACTERISTICS
7/13/21
Zinellu A, Sotgia S, Carru C, et al. | Front Cardiovasc Med
Aim: To conduct a meta-regression of studies reporting plasma BNP or NT-proBNP concentrations in COVID-19 patients with different disease severity.
CLINICAL CHARACTERISTICS
7/13/21
Barman A, Roy SS, Sasidharan SK, et al. | Spinal Cord Ser Cases
Aim: To summarise the clinical features and prognosis of persons with spinal cord injury (SCI) infected with COVID-19.
CLINICAL CHARACTERISTICS
7/13/21
Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al.  | Front Med
Aim: To systematically review the literature on COVID-19 co-infections with the influenza virus (type A and/or B).
CLINICAL CHARACTERISTICS
7/13/21
Akobeng AK, Grafton-Clarke C, Abdelgadir I, et al. | Frontline Gastroenterol
Aim: To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms.
UPDATED
CLINICAL CHARACTERISTICS
7/13/21
Hariyanto TI, Lugito NPH, Yanto TA, et al. | Endocr Metab Immune Disord Drug Targets
Aim: To evaluate the possible association between insulin and the poor composite development of COVID-19.
CLINICAL CHARACTERISTICS
7/13/21
Raeisi T, Mozaffari H, Sepehri N, et al. | Eat Weight Disord
Aim: To evaluate the global prevalence of obesity in COVID-19 patients and to investigate whether obesity is a risk factor for the COVID-19, COVID-19 severity, and its poor clinical outcomes including hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, and mortality.
CLINICAL CHARACTERISTICS
7/12/21
Shi C, Wang L, Ye J, et al. | BMC Infect Dis
Aim: To assess the potential predictors of mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/12/21
Savage HR, Santos VS, Edwards T, et al. | PLoS Negl Trop Dis
Aim: To review the evidence on the proportion of individuals with SARS-CoV-2 neutralising antibodies after infection and how this proportion varies with selected covariates.
CLINICAL CHARACTERISTICS
7/12/21
Kollias A, Kyriakoulis KG, Kyriakoulis IG, et al. | Atherosclerosis
Aim: To review the evidence regarding statin treatment and COVID-19 related mortality.
CLINICAL CHARACTERISTICS
7/12/21
Mansory E, Srigunapalan S, Lazo-Langner A | TH Open
Aim: To evaluate the epidemiology of VTE in hospitalized intensive care unit (ICU) and non-ICU patients.
UPDATED
CLINICAL CHARACTERISTICS
7/10/21
Umashankar A, Prakash P, Prabhu P | Indian J Otolaryngol Head Neck Surg
Aim: To review case reports related to sudden sensorineural hearing loss and COVID-19.
CLINICAL CHARACTERISTICS
7/9/21
Schwartzberg L, Advani S, Clancy DC, et al. | Skin Health Dis
Aim: To summarize cutaneous manifestations associated with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
7/9/21
Barssoum K, Victor V, Salem A, et al. | Echocardiography
Aim: To provide an overview of current findings and recommendations in cardiovascular imaging in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/9/21
Rathore SS, Rojas GA, Sondhi M, et al. | Int J Clin Pract
Aim: To compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19.
CLINICAL CHARACTERISTICS
7/8/21
Ramlah R | Ann Hepatobiliary Pancreat Surg
Aim: To determine the relationship between COVID-19 and acute pancreatitis.
CLINICAL CHARACTERISTICS
7/8/21
Najt P, Richards HL, Fortune D | Brain Behav Immun Health
Aim: To synthesise the potential evidence of the brain correlates of SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Gaythorpe K, Bhatia S, Mangal T, et al. | Sci Rep
Aim: To review the evidence on the susceptibility of children to SARS-CoV-2 infection, the severity and clinical outcomes in children with SARS-CoV-2 infection, and the transmissibility of SARS-CoV-2 by children.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Ulloque-Badaracco JR, Salas-Tello WI, Al-Kassab-Cordova A, et al. | Int J Clin Pract
Aim: To evaluate the prognostic value of the NLR in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Chisale MRO, Ramazanu S, Mwale SE, et al. | Rev Med Virol
Aim: To estimate the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in residents of African countries and explore its associated factors.
UPDATED
CLINICAL CHARACTERISTICS
7/7/21
Soltani S, Faramarzi S, Zandi M, et al. | New Microbes New Infect
Aim: To systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles.
CLINICAL CHARACTERISTICS
7/7/21
Zinellu A, Sotgia S, Fois AG, et al. | Adv Med Sci
Aim: To review the evidence on serum CK-MB concentrations in COVID-19 patients with different disease severity, based on clinical guidelines or need for hospitalization, mechanical ventilation, or transfer to the ICU, and survival status during follow up.
CLINICAL CHARACTERISTICS
7/7/21
Pardhan S, Wood S, Vaughan M, et al. | Front Med
Aim: To examine the adjusted risk of COVID-19 related hospitalsation, intensive care unit (ICU) admission, and mortality in patients with vs. without asthma or COPD.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Kremer D, Pieters TT, Verhaar MC, et al. | Am J Transplant
Aim: To assess all current evidence to provide an updated and robust insight in the clinical course and outcome of COVID-19 in KTR.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lassi ZS, Ana A, Das JK, et al. | J Glob Health
Aim: To determine the clinical presentation, risk factors, and pregnancy and perinatal outcomes in pregnant women with confirmed COVID-19 and identify if these are different based on COVID-19 severity.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Correia de Sá T, Soares C, Rocha M | World J Gastrointest Surg
Aim: To review and to explore the relationship between SARS-CoV-2 infection and AP, and to provide an overview of the existing literature on possible mechanisms of SARS-CoV-2-induced pancreatic lesion.
CLINICAL CHARACTERISTICS
7/6/21
Lee AC, Tse Li W, Apostol L, et al. | Comput Struct Biotechnol J
Aim: To examine the extent that age influences correlation results and by analyzing patients with severe COVID-19 and patients who died from COVID-19 separately.
CLINICAL CHARACTERISTICS
7/6/21
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Pathogens
Aim: To calculate the prevalence of coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Omidi F, Hajikhani B, Kazemi SN, et al. | Front Cardiovasc Med
Aim: To systematically review the current published literature to evaluate clinical and paraclinical characteristics of CMPs in patients infected with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Dube R, Kar SS | BMJ Paediatr Open
Aim: To determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity.
CLINICAL CHARACTERISTICS
7/6/21
Eljaaly K, Malibary H, Alsulami S, et al. | Pathogens
Aim: To describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
CLINICAL CHARACTERISTICS
7/6/21
Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, et al. | Syst Rev
Aim: To review the evidence on the relation between individual co-morbidities and disease severity (e.g., as measured by ICU admission) and further identify potential interactions with age.
CLINICAL CHARACTERISTICS
7/6/21
Wibowo A, Pranata R, Lim MA, et al. | Int J Infect Dis
Aim: To compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lee SA, Park R, Yang JH, et al. | Sci Rep
Aim: To investigate the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patients through meta-analysis.
CLINICAL CHARACTERISTICS
7/6/21
Singh AK, Singh R, Joshi SR, et al. | Diabetes Metab Syndr
Aim: To find out the patient's characteristics having mucormycosis and COVID-19.
CLINICAL CHARACTERISTICS
7/6/21
Mude W, Oguoma VM, Nyanhanda T, et al. | J Glob Health
Aim: To review the evidence on disparities in prevalence, hospitalisation, and deaths from COVID-19 by racial minority populations.
CLINICAL CHARACTERISTICS
7/6/21
Foret T, Dufrost V, du Mont LS, et al. | Curr Rheumatol Rep
Aim: To analyze the frequency of aPL in COVID-19 patients in different settings and to evaluate their persistence over time and to analyze the role of aPL during the infection in particular their participation in thrombotic events.
CLINICAL CHARACTERISTICS
7/6/21
Romero Starke K, Mauer R, Karskens E, et al. | Int J Environ Res Public Health
Aim: To collect evidence on the impact of temperature and humidity on COVID-19 mortality. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Beukes E, Ulep AJ, Eubank T, et al. | J Clin Med
Aim: To systematically review what has been published regarding tinnitus during the coronavirus disease 2019 (COVID-19) pandemic up to March 2021.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Akbar MR, Pranata R, Wibowo A, et al. | Front Med
Aim: To assess the prognostic value of hyponatremia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/2/21
Zein AFMZ, Sulistiyana CS, Khasanah U, et al. | Postgrad Med J
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Melo AKG, Milby KM, Caparroz ALMA, et al. | PLoS One
Aim: To describe the laboratory parameters and biomarkers of the cytokine storm syndrome associated with severe and fatal COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Ciapponi A, Bardach A, Comande D, et al.  | PLoS One
Aim: To summarize the best evidence regarding the effect of COVID-19 on maternal and child health.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Taylor EH, Marson EJ, Elhadi M, et al. | Anaesthesia
Aim: To determine factors associated with mortality among adults with COVID-19 admitted to intensive care.
CLINICAL CHARACTERISTICS
7/1/21
Kula B, Clancy CJ, Nguyen MG, et al. | Lancet Microbe
Aim: To establish the prevalence of autopsy-proven tissue-invasive IMD and analyse individual-level data to assess potential risk factors.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Sitek AN, Ade JM, Chiarella SE, et al. | Allergy Asthma Proc
Aim: To review the evidence on whether asthma is a risk factor associated with worse outcomes among patients with COVID-19.
CLINICAL CHARACTERISTICS
7/1/21
MH Aghdam, Hosseinzadeh R | Rev Med Microbiol
Aim: To discuss the involvement of the body's systems during COVID-19 infection comprehensively.
CLINICAL CHARACTERISTICS
7/1/21
Agrafiotis AC, Rummens P, Lardinois I | J Thorac Dis
Aim: To systematically review all the cases of spontaneous pneumothorax that occurred in healthy patients with no underlying lung disease and who did not receive invasive mechanical ventilation.
CLINICAL CHARACTERISTICS
6/30/21
Arian M, Valinejadi A, Vakilian F | Iran J Public Health
Aim: To report the findings of the first Electrocardiography (ECG), before therapy initiation and receiving medication in COVID-19 patients, and to compare them with the ECG findings of healthy men.
CLINICAL CHARACTERISTICS
6/29/21
Iqbal U, Anwar H, Siddiqui Hux, et al. | Clin Endosc
Aim: To evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB).
CLINICAL CHARACTERISTICS
6/29/21
Crafa A, Cannarella R, Condorelli RA, et al. | EClinicalMedicine
Aim: To assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/28/21
Ramadan MS, Bertolino L, Zampino R, et al. | Clin Microbiol Infect
Aim: To assess the range of cardiac sequelae after COVID-19 recovery.
CLINICAL CHARACTERISTICS
6/28/21
Song WL, Zou N, Guan WH, et al. | World J Pediatr
Aim: To assess clinical profiles of COVID-19 in family clusters with children.
CLINICAL CHARACTERISTICS
6/28/21
Teles Abrao Trad A, Ibirogba ER, Elrefaei A, et al. | Hypertens Pregnancy
Aim: To add to the growing evidence on SARS-CoV-2 infection during pregnancy, so as to better inform clinical decision making and optimize patient outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Mark EG, McAleese S, Golden WC, et al. | Pediatr Infect Dis J
Aim: To review outcomes in pregnant women with COVID-19 and neonates with perinatal exposure.
CLINICAL CHARACTERISTICS
6/28/21
Figueiro-Filho EA, Yudin M, Farine D, et al. | J Perinat Med
Aim: To identify the most significant studies reporting on COVID-19 during pregnancy and to provide an overview of SARS-CoV-2 infection in pregnant women and perinatal outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Silva CRACD, Oliveira LV, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the immunological aspects of the 2019 coronavirus disease (COVID-19) in pregnancy.
CLINICAL CHARACTERISTICS
6/28/21
Kim CNH, Hutcheon J, van Schalkwyk J, et al. | Am J Obstet Gynecol
Aim: To estimate the CFR of pregnant women infected with SARS-CoV-2 admitted to the intensive care unit (ICU). 
CLINICAL CHARACTERISTICS
6/28/21
Irani M, Pakfetrat A, Mask MK, et al. | J Educ Health Promot
Aim: To evaluate the association of COVID-19 and perinatal outcomes in pregnant women.
CLINICAL CHARACTERISTICS
6/28/21
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. | Eur J Intern Med
Aim: To analyze the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 .
CLINICAL CHARACTERISTICS
6/28/21
Bellou V, Tzoulaki I, van Smeden M, et al. | Eur Respir J
Aim: To present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/25/21
Ren X, Wang X, Ge Z, et al. | Int J Immunopathol Pharmacol
Aim: To examine immune function status-related manifestations and laboratory indicators of COVID-19 patients with recurrent virus PCR positivity.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Bobrovitz N, Arora R, Cao C, et al.  | PLoS ONE
Aim: To synthesize seroprevalence data to better estimate the burden of SARS-CoV-2 infection, identify high-risk groups, and inform public health decision making.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Zinellu A, Mangoni A | Front Immunol
Aim: To investigate possible differences in the serum concentrations of two routinely measured complement components, C3 and C4, in COVID-19 patients with different severity and survival status.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Yamamoto S, Saito M, Tamura A, et al. | PLoS One
Aim: To evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize this data in the pandemic era.
UPDATED
CLINICAL CHARACTERISTICS
6/24/21
Wang Z, Joshi A, Leopold K, et al. | Clin Endocrinol
Aim: To evaluate the association between vitamin D deficiency and severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
6/24/21
Samidoust P, Nikoupour H, Hemmati H, et al. | Ethiop J Health Sci
Aim: To explore available information on clinical presentations, laboratory finding and outcomes of SARS-COV-2 in liver transplant patients.
CLINICAL CHARACTERISTICS
6/24/21
Diaz-Arocutipa C, Carvallo-Castaneda D, Luis-Ybanez O, et al. | Clin Transplant
Aim: To summarize the clinical features, treatment, and outcomes of heart transplant recipients with COVID-19. 
CLINICAL CHARACTERISTICS
6/24/21
Gajbhiye RK, Sawant MS, Kuppusamy P, et al. | Int J Gynaecol Obstet
Aim: To compare clinical perinatal outcomes of women with COVID-19 from high-income countries (HICs) and low- to middle-income countries (LMICs).
CLINICAL CHARACTERISTICS
6/23/21
Tripathy SK, Varghese P, Panigrahi S, et al. | Chin J Traumatol
Aim: To evaluate the 30-day mortality and complications in COVID-19 + and COVID-19 ? patients with hip fractures.
UPDATED
CLINICAL CHARACTERISTICS
6/23/21
Dautzenberg B, Levi A, Adler M, et al. | Respir Med Res
Aim: To conduct a systematic analysis of the nicotine doses used, the duration of use, the progressive increase or decrease of the doses, the side-effects leading, or not, to an interruption of the treatment, and the risk of developing a nicotine addiction in non-smokers.
CLINICAL CHARACTERISTICS
6/22/21
Manca R, De Marco M, Ince PG, et al. | Front Aging Neurosci
Aim: To summarize the literature on neuroimaging and neuropathological findings in older over-60 patients with COVID-19 following a cognitive neuroscientific perspective, to clarify the most vulnerable brain areas and speculate on the possible cognitive consequences.
CLINICAL CHARACTERISTICS
6/22/21
Kumar A, Haider Y, Passey J, et al. | Bull Emerg Trauma
Aim: To analyze the factors associated with mortality in fracture patients with concomitant COVID-19 infection based on the available published data.
CLINICAL CHARACTERISTICS
6/21/21
Amdal CD, Pe M, Falk RS, et al. | Qual Life Res
Aim: To identify all relevant health-related quality of life (HRQoL) issues associated with COVID-19.
CLINICAL CHARACTERISTICS
6/21/21
Prakash A, Singh H, Sarma P, et al.  | Sci Rep
Aim: To discuss the prevalence of neurological involvement of the 2019-nCoV patients and assess the symptomatic trend of events as compared to the 2002 "SARS" and 2012 "MERS" pandemics. 
CLINICAL CHARACTERISTICS
6/21/21
Christensen J, O'Callaghan K, Sinclair H, et al. | Intern Med J
Aim: To review the evidence on subacute thyroiditis secondary to COVID-19.
CLINICAL CHARACTERISTICS
6/18/21
Pal R, Singh B, Bhadada SK, et al. | Mycoses
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
6/18/21
Chua PEY, Shah SU, Gui H, et al. | J Investig Med
Aim: To compare clinical presentation, outcomes, and care management among patients with COVID-19 during the early phase of the pandemic.
CLINICAL CHARACTERISTICS
6/17/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | PLoS Negl Trop Dis
Aim: To evaluate the prevalence and case fatality rate of COVID-19 in patients with ESRD with RRT.
UPDATED
CLINICAL CHARACTERISTICS
6/17/21
Yusuf F, Fahriani M, Mamada SS, et al. | F1000Res
Aim: To determine the cumulative prevalence of prolonged gastrointestinal (GI) symptoms, including nausea, vomiting, diarrhea, lack of appetite, abdominal pain, and dysgeusia, in survivors of both mild and severe COVID-19 worldwide and to discuss the potential pathogenesis.  
UPDATED
CLINICAL CHARACTERISTICS
6/17/21
Raina R, Mahajan ZA, Vasistha P, et al. | Blood Purif
Aim: To review the evidence on the incidence and outcomes of AKI in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/16/21
Taheri L, Gheiasi SF, Taher M, et al. | Compr Child Adolesc Nurs
Aim: To identify and summarize the existing evidence on clinical characteristics of COVID-19 in pediatric patients. 
UPDATED
CLINICAL CHARACTERISTICS
6/16/21
Ramanathan K, Shekar K, Ling RR, et al. | Crit Care
Aim: To summarise outcome data during the first year of the pandemic and identify risk factors for an unfavourable outcomes in order to guide clinical decision-making and further research.
UPDATED
CLINICAL CHARACTERISTICS
6/15/21
Buso G, Becchetti C, Berzigotti A | Dig Liver Dis
Aim: To review the evidence on acute splanchnic vein thrombosis in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/15/21
He Y, Wang J, Ren J, et al. | Front Endocrinol
Aim: To provide a comprehensive overview of the topic of whether COVID-19 can impact on male reproductive system.
CLINICAL CHARACTERISTICS
6/15/21
Iloanusi S, Mgbere O, Essien EJ | J Am Pharm Assoc
Aim: To summarize the available literature on the association between polypharmacy and specific drug classes, and clinical outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
6/14/21
Li Y, Deng Y, Ye L, et al. | Front Med
Aim: To illuminate the clinical significance of plasma D-dimer in COVID-19 mortality.
CLINICAL CHARACTERISTICS
6/14/21
Pizuorno A, Fierro NA, Copado-Villagrana ED, et al. | BMC Infect Dis
Aim: To study the symptoms and comorbidities that associate with this pandemic in 3 different regions of Mexico.
CLINICAL CHARACTERISTICS
6/14/21
Chan KW, Yu KY, Lee PW, et al. | Front Med
Aim: To assess the association between AKI, mortality, underlying non-communicable diseases, and clinical risk factors.
UPDATED
CLINICAL CHARACTERISTICS
6/14/21
Xin H, Wong JY, Murphy C, et al. | Clin Infect Dis
Aim: To review published estimates of the incubation period distribution with a particular interest in the methodology applied and potential biases.
CLINICAL CHARACTERISTICS
6/14/21
Kay I, Madran B, Keske S, et al. | Clin Microbiol Infect
Aim: To investigate the seroprevalence of SARS-CoV-2 among HCWs and related risk factors.
CLINICAL CHARACTERISTICS
6/12/21
Lewis A, Frontera J, Placantonakis DG, et al. | Clin Neurol Neursurg
Aim: To review the literature on cerebrospinal fluid (CSF) testing in patients with altered olfactory/gustatory function due to COVID-19 for evidence of viral neuroinvasion.
CLINICAL CHARACTERISTICS
6/11/21
Harrison SL, Buckley BJR, Rivera-Caravaca JM, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health.
CLINICAL CHARACTERISTICS
6/11/21
Akbar M, Pranata R, Wibowo A, et al | Eur Rev Med Pharmacol Sci
Aim: To evaluate the association between the prealbumin and severity and mortality in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/10/21
SeyedAlinaghi S, Mirzapour P, Dadras O, et al. | Eur J Med Res
Aim: To characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality.
CLINICAL CHARACTERISTICS
6/10/21
Lewis A, Jain R, Frontera J, | J Neuroimaging
Aim: To evaluate cerebrospinal fluid (CSF) results from patients with coronavirus disease 2019 (COVID-19) who had neurological symptoms and had an MRI that showed (1) central nervous system (CNS) hyperintense lesions not attributed to ischemia and/or (2) leptomeningeal enhancement. 
CLINICAL CHARACTERISTICS
6/10/21
Guimarães D, Pissarra R, Reis-Melo A, et al. | Int J Clin Pract
Aim: To analyze current literature and reported cases of MISC, concerning its clinical spectrum, complications associated, therapeutic strategies and distinguishing features of other clinical syndromes.
CLINICAL CHARACTERISTICS
6/9/21
Asiimwe IG, Pushpakom S, Turner R, et al | Br J Clin Pharmacol
Aim: To continually evaluate the rapidly evolving evidence base on the role of cardiovascular drugs in COVID-19 clinical outcomes (susceptibility to infection, hospitalization, hospitalization length, disease severity, and all-cause mortality).
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Nikoloski Z, Alqunaibet AM, Alfawaz RA, et al. | BMC Public Health
Aim: To systematize the available evidence on the link between non-communicable diseases and Covid-19.
CLINICAL CHARACTERISTICS
6/8/21
Yang J, D'souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To conduct a living systematic review and meta-analyses of studies reporting pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Mohan N, Fayyaz MA, Del Rio C, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To evaluate and correlate the neuro-radiological and neurological manifestations in patients diagnosed with SARS-CoV2.To identify neuro-invasive pathways of COVID infection.
CLINICAL CHARACTERISTICS
6/8/21
Sarkar S, Kannan S, Khanna P, et al. | Rev Med Virol
Aim: To explore the utility of RDW in the prognosis of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Zugaj M, van Ditzhuijzen NS, Golebski K, et al. | Rhinology
Aim: To review the effects of the 7 known human coronaviruses on olfaction to determine if SARS-CoV-2 distinctly affects the olfactory system.
CLINICAL CHARACTERISTICS
6/7/21
Liu X, Wang H, Shi S, et al. | Postgrad Med J
Aim: To evaluate the association between IL-6 and severe disease and mortality in COVID-19 disease.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Guerrero JI, Barragan LA, Martinez JD, et al. | BMC Infect Dis
Aim: To describe the features of the central and peripheral nervous system involvement by COVID-19 in terms of pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Messina A, Sanfilippo F, Milani A, et al. | J Crit Care
Aim: To summarise the current knowledge regarding cardiac dysfunction in COVID-19 as assessed by echocardiography, both in ICU and non-ICU subjects.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Zuin M, Rigatelli G, Bilato C, et al. | Acta Cardiol
Aim: To evaluate the pooled incidence of acute HF as a cardiac complication of COVID-19 disease and to estimate the related mortality risk in these patients.
CLINICAL CHARACTERISTICS
6/7/21
Siracusa L, Cascio A, Giordano S, et al. | Ital J Pediatr
Aim: To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement.
CLINICAL CHARACTERISTICS
6/7/21
Rogers JP, Watson CJ, Badenoch J, et al. | J Neurol Neurosurg Psychiatry
Aim: To describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Chong WH, Saha BK, Hu K, et al. | Heart Lung
Aim: To describe the incidence, clinical characteristics, and outcomes of COVID-19-related pneumothorax.
CLINICAL CHARACTERISTICS
6/7/21
Mai V, Tan BK, Mainbourg S, et al. | Vascul Pharmacol
Aim: To compare the rate of VTE between COVID-19 and non-COVID-19 cohorts with similar disease severity.
CLINICAL CHARACTERISTICS
6/3/21
Reyes FM, Hache-Marliere M, Karamanis D, et al. | J Clin Med
Aim: To explore the association of COPD and asthma with in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/3/21
Jimenez-Cebrian AM, Castro-Mendez A, Garcia-Podadera B, et a;/ | J Clin Med
Aim: To analyze and synthesize the published reviews on manifestations of COVID-19 at the foot level. 
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Leyser M, Marques FJP, do Nascimento OJM | Rev Paul Pediatr
Aim: To perform a systematic literature review to analyze existing data on the neurological effects of coronavirus on newborns.
CLINICAL CHARACTERISTICS
6/3/21
Santana MAC, Cano JAA, Kanan AD, et al. | Medicina
Aim: To contrast the existing evidence regarding the relationship between periodontal disease (PD) and diabetes mellitus (DM) with the possibly increased risk of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/3/21
Wang R, Liu M, Liu J | Vaccines
Aim: To assess the association between influenza vaccination and SARS-CoV-2 infection and clinical outcomes.
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Khan DSA, Pirzada AN, Ali A, et al. | Int J Environ Res Public Health
Aim: To investigate the differences in clinical presentation, management, and prognosis of COVID-19 infection in pregnant and non-pregnant women.
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Ippolito M, Misseri G, Catalisano G, et al. | Antibiotics
Aim: To estimate the pooled occurrence of ventilator-associated pneumonia (VAP) among patients admitted to an intensive care unit with COVID-19 and mortality of those who developed VAP.
CLINICAL CHARACTERISTICS
6/2/21
Franchini M, Cruciani M, Mengoli C, et al. | Blood Transfus
Aim: To assess the relationship between the ABO blood group and the occurrence and severity of COVID-19.
CLINICAL CHARACTERISTICS
6/2/21
Wang MX, Gwee SXW, Pang J | Nutrients
Aim: To systematically assess the associations between micronutrient supplementation or deficiency, with novel coronavirus incidence and disease severity.
UPDATED
CLINICAL CHARACTERISTICS
6/2/21
Schulte EC, Hauer L, Kunz AB, et al. | Eur J Neurol
Aim: To review cases of ATM described in the context of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
CLINICAL CHARACTERISTICS
6/1/21
Grove A, Osokogu O, Al-Khudairy L, et al. | BMJ Open
Aim: To systemically review and critically appraise published studies of the association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19, including clinical course, morbidity and mortality outcomes.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
Dumitrascu F, Branje KE, Hladkowicz ES, et al. | J Am Geriatr Soc
Aim: To identify, describe, and synthesize studies reporting the association of frailty with outcomes (informed by the Institute for Healthcare Improvement's Triple Aim [health, resource use, and experience]) in individuals with COVID-19.
CLINICAL CHARACTERISTICS
6/1/21
Carroll E, Melmed KR, Frontera J, et al. | Seizure
Aim: To review the CSF results in published case reports and case series of patients with COVID-19 who had seizures to evaluate for evidence of viral neuroinvasion.
CLINICAL CHARACTERISTICS
6/1/21
da Silva RP, Goncalves JIB, Zanin RF, et al. | Front Immunol
Aim: To summarize the available evidence of the association of plasma protein levels of type I IFN with the severity of COVID-19.
CLINICAL CHARACTERISTICS
6/1/21
Bolia R, Goel AD, Badkur M, et al. | J Trop Pediatr
Aim: To determine the GI manifestations of pediatric COVID-19 and to evaluate their role as risk factors for a severe clinical course.
CLINICAL CHARACTERISTICS
6/1/21
Kaur H, Thakur JS, Paika R, et al. | Asian Pac J Cancer Prev
Aim: To explore the prevalence of comorbidities among cancer patients with SARS CoV-2 infection and their impact on mortality.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
Tagliamento M, Agostinetto E, Bruzzone M, et al. | Crit Rev Oncol Hematol
Aim: To estimate the mortality in patients with cancer and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/1/21
Singh S, Verma N, Kanaujia R, et al. | Mycoses
Aim: To synthesize the results of primary studies on CAPA and to provide pooled mortality estimators of in-hospital mortality of the disease and potential predictors of outcome.
CLINICAL CHARACTERISTICS
6/1/21
Almazroa A, Alamri S, Alabdulkader B, et al. | Int Health
Aim: To review the evidence on ocular transmission and manifestations of SARS-CoV-2.
CLINICAL CHARACTERISTICS
6/1/21
Zawawi A, Naser AY, Alwafi H, et al. | Front Immunol
Aim: To evaluate the inflammatory cytokines profile associated with severe human coronavirus diseases, including three stains: MERS-CoV, SARS-CoV SARS-CoV-2, in severe patients.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
O Murchu E, Byrne P, Carty PG, et al. | Rev Med Virol
Aim: To evaluate the risk and relative risk of SARS-CoV-2 reinfection over time, comparing previously infected individuals to those without evidence of prior infection.
CLINICAL CHARACTERISTICS
6/1/21
Hou H, Li Y, Zhang P, et al. | Nicotine Tob Res
Aim: To explore the association between smoking and mortality of coronavirus disease 2019 (COVID-19) patients utilizing a quantitative meta-analysis on the basis of adjusted effect estimates.
CLINICAL CHARACTERISTICS
6/1/21
Kabrah SM, Kabrah AM, Flemban AF, et al. | Transfus Apher Sci
Aim: To evaluate the existing evidence on the susceptibility of the ABO blood group to COVID-19 infection.
CLINICAL CHARACTERISTICS
5/28/21
Nasserie T, Hittle M, Goodman SN | JAMA Netw Open
Aim: To conduct a systematic review of studies examining the frequency and variety of persistent symptoms after COVID-19 infection.
CLINICAL CHARACTERISTICS
5/28/21
Iqbal FM, Lam K, Sounderajah V, et al. | EClinicalMedicine
Aim: To characterise the clinical features between acute and chronic post-COVID syndrome.
UPDATED
CLINICAL CHARACTERISTICS
5/28/21
Kastora S, Kounidas G, Perrott S, et al. | EClinicalMedicine
Aim: To quantify the impact of clinical frailty scale (CFS) by increasing severity of frailty and to identify other personal prognostic factors associated with increased mortality from COVID-19.
CLINICAL CHARACTERISTICS
5/28/21
Panda S, Nanda R, Tripathy PK, et al. | J Family Med Prim Care
Aim: To summarize the alteration in the immunological and inflammatory markers of COVID-19 cases reported in currently available observational studies and their associations with the severity of disease process.
CLINICAL CHARACTERISTICS
5/28/21
Fahmy OH, Daas FM, Salunkhe V, et al. | Crit Care Explor
Aim: To retrieve and report the findings of postmortem studies including the histopathologic data of deceased coronavirus disease 2019 patients and to review the manifestations of coronavirus disease 2019–associated thrombotic pathologies reported in the recent literature.
CLINICAL CHARACTERISTICS
5/28/21
de Sousa Neto AR, de Carvalho ARB, de Oliveira EMN, et al. | Rev Gaucha Enferm
Aim: To identify symptoms of COVID-19 in adults in the scientific literature.
CLINICAL CHARACTERISTICS
5/24/21
Massarvva T | Epidemiol Health
Aim: To systematically review up-to-date studies reporting on the clinical outcomes of COVID-19 amongst HIV patients.
CLINICAL CHARACTERISTICS
5/24/21
Barzegar M, Mirmosayyeb O, Gajarzadeh M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To systematically review the literature on COVID-19 in patients with multiple sclerosis (MS).
CLINICAL CHARACTERISTICS
5/24/21
Shah S, Akhade K, Ganguly S, et al. | J Family Med Prim Care
Aim: To summarize the major patterns of dermatological manifestations associated with SARS-CoV-2 virus infection.
CLINICAL CHARACTERISTICS
5/24/21
Chmielewska B, Barratt I, Townsend R, et al. | Lancet Glob Health
Aim: To assess the collateral effects on maternal, fetal, and neonatal outcomes of the global COVID-19 pandemic.
CLINICAL CHARACTERISTICS
5/24/21
SeyedAlinaghi S, Mehrtak M, MohsseniPour M, et al. | Eur J Med Res
Aim: To investigate the available evidence for the genetic susceptibility to COVID-19.
CLINICAL CHARACTERISTICS
5/24/21
Salamanna F, Veronesi F, Martini L, et al. | Front Med
Aim: To assess the current evidence on the long-term symptoms in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/24/21
Abate SM, Chekole YA, Estifanos MB, et al. | Clin Nutr ESPEN
Aim: To investigate the prevalence and outcome of malnutrition among patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/24/21
Mathew HR, Choi MY, Parkins MD, et al. | BMC Pulm Med
Aim: To systematically survey published accounts of COVID-19 in CF and determine if individuals with CF are disproportionally affected by SARS-CoV-2 and development of COVID-19.
CLINICAL CHARACTERISTICS
5/21/21
Singhal S, Kumar P, Singh S, et al. | BMC Geriatr
Aim: To review the evidence on the clinical characteristics of older COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Bzeizi K, Abdulia M, Mohammed N, et al. | Sci Rep
Aim: To assess the available evidence on the clinical effects of SARS-CoV-2 on liver function laboratory tests and coagulation profile in affected individuals. 
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Xiong X, Chi J, Gao Q | Thromb J
Aim: To determine the prevalence and risk factors of thrombotic events on COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/20/21
Alcock H, Moppett EA, Moppett IK | Bone Jt Open
Aim: To understand the impact of coexistent hip fracture and SARS-CoV-2 for informed decision-making at patient and service levels.
CLINICAL CHARACTERISTICS
5/20/21
Manoharan L, Cattrall JW, Harris C, et al. | PLoS One
Aim: To summarize the early literature on clinical characteristics of patients admitted to hospital, and evaluates the quality of evidence produced during the initial stages of the pandemic.
CLINICAL CHARACTERISTICS
5/20/21
Haghpanah A, Masjedi F, Salehipour M, et al. | Prostate Cancer Prostatic Dis
Aim: To explore the potential mechanisms of SARS-CoV-2 in targeting the prostate gland, leading to exacerbation of benign prostatic hyperplasia (BPH) symptoms and greater risks of BPH complications such as acute urinary retention.
CLINICAL CHARACTERISTICS
5/20/21
Pannone G, Caponio VCA, De Stefano IS, et al. | Infect Agent Cancer
Aim: To summarize lung histopathological characteristics of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/20/21
Dhar D, Dey T, Samim MM, et al. | Pediatr Res
Aim: To review the evidence on the demographic profile, clinical characteristics, complications, management, and prognosis of MIS-C associated with COVID-19.
CLINICAL CHARACTERISTICS
5/19/21
Scheiner NS, Smith AK, Wohlleber M, et al. | J Acad Consult Liaison Psychiatry
Aim: To review the extant literature describing catatonia in the setting of COVID-19 disease and highlight commonalities among the cases.
CLINICAL CHARACTERISTICS
5/19/21
Azab MA, Azzam AY | Brain Disord
Aim: To perform a meta-analysis of the available published data concerning the management of glioma patients in the published literature from the beginning of the pandemic to the end of 2020 concerning the number of operated surgeries, postoperative complications, and mortality outcomes.
CLINICAL CHARACTERISTICS
5/19/21
Quesada JA, Lopez-Pineda A, Gil-Guillen VF, et al. | Rev Clin Esp
Aim: To provide a more accurate estimate of the incubation period of COVID-19.
CLINICAL CHARACTERISTICS
5/17/21
Bircakova B, Bruha R, Lambert L, et al. | Scand J Gastroenterol
Aim: To review clinical and laboratory findings in patients with SARS-Cov-2 (COVID-19) related acute pancreatitis.
CLINICAL CHARACTERISTICS
5/17/21
Hernandez-Perez A, Garcia-Gomez L, Rodriguez-Llamazares S, et al. | Salud Publica Mex
Aim: To describe the possible risks associated to smoking in the spread and complications of Covid-19, emphasizing in the benefits of quitting smoking.
CLINICAL CHARACTERISTICS
5/17/21
Shao SC, Lai CC, Chen YH, et al. | Age Aging
Aim: To summarize the evidence on prevalence, incidence and mortality of delirium in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/17/21
Wingert A, Pillay J, Gates M, et al. | BMJ Open
Aim: To determine the magnitude of association between potential risk factors and severity of COVID-19, to inform vaccine prioritisation in Canada.
CLINICAL CHARACTERISTICS
5/17/21
Severo Bem Junior L, do Rego Aquino PL, Nunes Rabelo N, et al. | J Neurol Res
Aim: To reveal the current knowledge regarding CNS manifestation in SARS-CoV-2. 
CLINICAL CHARACTERISTICS
5/17/21
Mitra S, Ling RR, Yang IX, et al. | Ann Acad Med Singap
Aim: To review the evidence on COVID-19-induced coagulopathy.
CLINICAL CHARACTERISTICS
5/14/21
Biswas M, Most SKK | Sci Rep
Aim: To assess aggregated risk by investigating the association of ACEIs/ARBs users against non-users of ACEIs/ARBs with the risk of mortality or severe clinical manifestations or magnitude of SARS-CoV-2 test positivity in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/14/21
Soeroto AY, Purwiga A, Pranggono EH, et al. | Asian Pac J Allergy Immunol
Aim: To investigate the association between asthma and composite poor outcome in patients with coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
5/14/21
Wu T, Yu P, Li Y, et al. | J Asthma
Aim: To analyze the association between COVID-19 and asthma.
CLINICAL CHARACTERISTICS
5/14/21
Lim KH, Soong F, Low YF, et al. | J Clin Virol
Aim: To determine the clinical manifestations of neonatal COVID-19 and outcomes based on severity groups. 
CLINICAL CHARACTERISTICS
5/14/21
Khodeir MM, Shabana HA, Alkhamiss AS, et al. | J Infect Public Health
Aim: To review different biomarkers to systematically analyze these values to evaluate whether are they are correlated with the severity of COVID-19 disease and so their ability to be a predictor for progression.
CLINICAL CHARACTERISTICS
5/14/21
Siow I, Lee KS, Zhang JJY, et al. | Eur J Neurol
Aim: To describe the incidence, clinical course and outcomes of patients who suffer from encephalitis as a complication of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
Chambergo-Michilot D, Barros-Sevillano S, Rivera-Torrejon O, et al. | Eur J Neurol
Aim: To systematically review the factors associated with COVID-19 in people with PD.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
Paternoster G, Bertini P, Innelli P, et al. | J Cardiothorac Vasc Anesth
Aim: To describe the features of right ventricular impairment and pulmonary hypertension in coronavirus disease (COVID-19) and assess their effect on mortality.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
James PT, Ali Z, Armitage AE, et al. | J Nutr
Aim: To review the latest evidence on how malnutrition across all its forms (under- and overnutrition and micronutrient status) may influence both susceptibility to, and progression of, COVID-19.
CLINICAL CHARACTERISTICS
5/13/21
Kang S, Gong X, Yuan Y | Epidemiol Infect
Aim: To systematically assess the association between smoking and cardiovascular disease and disease progression among novel coronavirus pneumonia (COVID-19) cases.
UPDATED
CLINICAL CHARACTERISTICS
5/13/21
Martimbianco ALC, Pacheco RL, Bagattini AM, et al. | Int J Clin Pract
Aim: To identify, systematically evaluate and summarise the best available evidence on the frequency of long COVID (post-acute COVID-19 syndrome), its clinical manifestations and the criteria used for diagnosis.
UPDATED
CLINICAL CHARACTERISTICS
5/12/21
Round T, L'Esperance V, Bayly J, et al. | Br J Cancer
Aim: To review the evidence on delivering lung cancer care during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
5/11/21
Keshavarz P, Yazdanpanah F, Azhdari S, et al. | J Med Virol
Aim: To demonstrate the relationship between severely ill cases of MIS-C and COVID-19.
CLINICAL CHARACTERISTICS
5/11/21
Zippi M, Fiorino S, Budriesi R, et al. | World J Clin Cases
Aim: To identify studies on the relationship between the intake of PPIs and coronavirus disease 2019 (COVID-19) in patients affected by SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
5/11/21
Las Casas Lima MH, Cavalcante ALB, Leão SC | Braz J Otorhinolaryngol
Aim: To analyze current scientific evidence intended to elucidate the pathophysiological relationship between COVID-19 and the cause of olfactory disorders.
CLINICAL CHARACTERISTICS
5/11/21
Oscanoa TJ, Amado J, Vidal X, et al. | Adv Respir Med
Aim: To conduct a metanalysis of the association between 25-hydroxyvitamin D (25(OH)D) concentration and SARS-CoV-2 infection severity or mortality.
CLINICAL CHARACTERISTICS
5/10/21
Kim H, Hwang H, Hong H, et al. | Sci Rep
Aim: To review the differences in risk factors for critical outcomes of patients with COVID-19 according to the continent on which the studies were performed.
CLINICAL CHARACTERISTICS
5/10/21
Ghodsi A, Bijari M, Alamdaran SA, et al. | World J Pediatr
Aim: To evaluate the chest computed tomography (CT) findings in infants with confirmed COVID-19 infection
CLINICAL CHARACTERISTICS
5/10/21
Menon T, Gandhi SAQ, Tariq W, et al. | Cureus
Aim: To provide an association between CKD and the clinical prognosis of COVID-19.
CLINICAL CHARACTERISTICS
5/10/21
Ippolito M, Catalisano G, Marino C, et al. | Resuscitation
Aim: To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR).
CLINICAL CHARACTERISTICS
5/10/21
Musuuza JS, Watson L, Parmasad V, et al. | PLoS One
Aim: To examine the occurrence of co-infections and superinfections and their outcomes among patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
5/7/21
Gulsen A, Konig I, Jappe U, et al. | Respirology
Aim: To examine in detail whether the underlying chronic obstructive pulmonary diseases (COPD), asthma and chronic respiratory diseases (CRDs) were associated with an increased risk of more severe COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Mutiawati E, Syahrul S, Fahriani M, et al. | F1000Res
Aim: To determine the prevalence of headache in coronavirus disease 2019 (COVID-19) and to assess its association as a predictor for COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Aladawi M, Elfil M, Abu-Esheh B, et al. | Can J Neurol Sci
Aim: To review the evidence on the association between Guillain Barre Syndrome and COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Dembrovszky F, Váncsa S, Farkas N, et al. | Viruses
Aim: To evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. 
UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Aldien AS, Ganesan GS, Wahbeh F, et al. | Cardiovasc Revasc Med
Aim: To investigate the possible role of hyperinflammation in inducing cardiac injury as one of the severe complications of COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Lu Y, Zhao J, Ye M, et al. | Neurol Sci
Aim: To determine the risk of acute ischemic stroke in patients with severe and non-severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/7/21
Cosco TD, Best J, Davis D, et al. | Age Aging
Aim: To quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients.
UPDATED
CLINICAL CHARACTERISTICS
5/6/21
Angelico R, Blasi F, Manzia TM, et al. | Medicina
Aim: To investigate the current management of IS therapy in KT recipients with COVID-19. 
CLINICAL CHARACTERISTICS
5/5/21
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
5/5/21
Li X, Zhong X, Wang Y, et al. | PLoS One
Aim: To systematically identify the possible risk factors responsible for severe cases.
CLINICAL CHARACTERISTICS
5/5/21
Rehman MA, Farooq H, Ali MM, et al. | SN Compr Clin Med
Aim: To identify cases of subacute thyroiditis associated with COVID-19 and evaluated patient-level demographics, major clinical features, laboratory findings and outcomes.
CLINICAL CHARACTERISTICS
5/4/21
Du P, Li D, Wang A, et al. | Can J Infect Dis Med Microbiol
Aim: To screen the risk factors for severe illness and death and provide help for early clinical treatment of the new coronavirus (COVID-19).
CLINICAL CHARACTERISTICS
5/4/21
Dos Santos ACM, Dos Santos BRC, Dos Santos BB, et al. | Infect Genet Evol
Aim: to review the effect of single nucleotide polymorphisms in the development of severe acute respiratory syndrome (SARS).
UPDATED
CLINICAL CHARACTERISTICS
5/4/21
Hariyanto TI, Rosalind J, Christian K, et al. | South Afr J HIV Med
Aim: To explore the impact of HIV and SARS-CoV-2 co-infection on mortality.
CLINICAL CHARACTERISTICS
5/4/21
Nepal G, Shrestha GS, Rehrig JH, et al. | J Nepal Health Res Counc
Aim: To review the evidence on neurological involvement in COVID-19 associated MIS-C.
CLINICAL CHARACTERISTICS
5/4/21
Liang M, Luo N, Chen M, et al. | Infect Dis Ther
Aim: To investigate the prevalence and mortality in PLWHA co-infected with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/3/21
Mogensen MA, Wangaryattawanich P, Hartman J, et al. | Br J Radiol
Aim: To describe outcomes associated with abnormal neuroimaging findings among adult COVID-19 patients.
CLINICAL CHARACTERISTICS
4/30/21
Lee J, Song J | J Med Virol
Aim: To investigate the diagnostic accuracy of the Xpert Xpress and the ID NOW assays for rapid detection of SARS-CoV-2.
CLINICAL CHARACTERISTICS
4/30/21
Peiris S, Mesa H, Aysola A, et al. | PLoS One
Aim: To summarize the reported pathologic findings on biopsy and autopsy in patients with severe/fatal COVID-19 and documented the presence and/or effect of SARS-CoV-2 in all organs.
CLINICAL CHARACTERISTICS
4/29/21
Choudary MC, Crain CR, Qiu X, et al.  | Clin Infect Dis
Aim: To characterize the hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.
UPDATED
CLINICAL CHARACTERISTICS
4/28/21
Hayward SE, Deal A, Cheng C, et al. | J Migr Health
Aim: To assess clinical outcomes of COVID-19 in migrant populations (cases, hospitalisations, deaths), indirect health and social impacts, and to determine key risk factors.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Sheikh AB, Chourasia PK, Javed N, et al. | J Neuroimmunol
Aim: To determine demographic characteristics, clinical features, lab evaluation, management and complications of the studies focusing on Guillain-Barre syndrome (GBS) as a sequele of novel coronavirus (COVID-19) infection.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Yu J, Wu B, Feng L, et al. | J Tissue Viability
Aim: To summarize the pressure injuries caused by COVID-19 and the corresponding preventive measures and treatments.
CLINICAL CHARACTERISTICS
4/27/21
Mitaka H, Kuno T, Takagi H, et al. | Mycoses
Aim: To determine the incidence and mortality of CAPA in critically ill patients with COVID-19 to improve guidance on surveillance and prognostication.
CLINICAL CHARACTERISTICS
4/27/21
Patralekh MK, Jain V, Iyengar K, et al.  | J Clin Orthop Trauma
Aim: To evaluate the impact of COVID-19 on patients with PFF and assessed associated mortality.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Wu Y, Li H, Zhang Z, et al. | Ann Palliat Med
Aim: To evaluate the in-hospital mortality and risk factors of death in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/26/21
Garcia-Zamora S, Lee S, Haseeb S, et al. | Pacing Clin Electrophysiol
Aim: To examine the prevalence of cardiac arrhythmias detected by the electrocardiogram and their relationships with adverse outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Ma Z, Wang MP, Liu L, et al. | Aging
Aim: To review the evidence on whether ACEI and/or ARB are associated with the risk of SARS-COV2 infection and whether they are associated with adverse outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Singh J, Malik P, Patel N, et al. | Clin Exp Med
Aim: To identify prevalence and association of comorbid chronic kidney disease (CKD), acute kidney injury (AKI) and utilization prevalence of continuous renal replacement therapy (CRRT) in COVID-19-hospitalized patients as a function of severity status. 
CLINICAL CHARACTERISTICS
4/26/21
Parsons N, Outsikas A, Parish A, et al. | AJNR Am J Neuroradiol
Aim: To quantitatively evaluate whether a network diffusion model can explain the spread of small neurologic events.
CLINICAL CHARACTERISTICS
4/26/21
Hariyanto TI, Kurniawan A | Sleep Med
Aim: To analyze the relationship between OSA and poor outcomes of COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Dmytriw AA, Chibbar R, Chen PPY, et al. | Expert Rev Respir Med
Aim: To review the evidence on the outcomes of patients with COVID-19-related ARDS compared to ARDS unrelated to COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Chong WH, Neu KP | J Hosp Infect
Aim: To discuss the incidence, characteristics, diagnostic criteria, biomarkers, and outcomes of hospitalized patients diagnosed with CAPA.
CLINICAL CHARACTERISTICS
4/26/21
Iwu CJ, Iwu CD, Wiysonge CS | Pan Afr Med J
Aim: To synthesize evidence on the long-term effects of the SARS-CoV-2 infection among survivors.
CLINICAL CHARACTERISTICS
4/22/21
Thakur B, Dubey P, Benitez J, et al.  | Sci Rep
Aim: To determine geographical, age, and gender related differences in the prevalence of comorbidities and associated severity and mortality rates among COVID-19 patients.
CLINICAL CHARACTERISTICS
4/22/21
Menon T, Sharma R, Saurabh K, et al.  | Cureus
Aim: To measure the prevalence of acute kidney injury (AKI) in COVID-19 and its association with the disease severity and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/21/21
Chowdhury AI, Alam MR, Rabbi MF, et al.  | Obes Med
Aim: To estimate the effects of overweight and obesity on COVID-19 disease severity.
CLINICAL CHARACTERISTICS
4/21/21
Medaglia AA, Siracusa L, Gioè C, et al.  | Ital J Pediatr
Aim: To review the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
4/21/21
Dy LF, Lintao RCV, Cordero CP, et al.  | Sci Rep
Aim: To estimate the proportion of COVID-19 patients with cardiac abnormalities and to determine the association between the cardiac abnormalities in COVID-19 patients and disease severity and mortality.
CLINICAL CHARACTERISTICS
4/20/21
Cheng MP, Cau A, Lee TC, et al.  | Crit Care Med
Aim: To compare the rates of cardiac injury by angiotensin-converting enzyme-2-binding viruses from viruses that do not bind to angiotensin-converting enzyme-2.
CLINICAL CHARACTERISTICS
4/20/21
Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R, et al.  | PeerJ
Aim: To understand the impact of COVID-19 on ADL performance of adult patients and to describe the common scales used to assess performance of ADL on patients post-COVID-19.
CLINICAL CHARACTERISTICS
4/20/21
Artemios A, Andreas L, Hadjigeorgiou L, et al. | Neurol Res
Aim: To characterize all – to date – reported cases with COVID-19 related myelopathy.
CLINICAL CHARACTERISTICS
4/20/21
Mondello C, Roccuzzo S, Malfa O, et al.  | Front Pharmacol
Aim: To review the main post-mortem findings reporting data on the infection effects on several organs.
CLINICAL CHARACTERISTICS
4/20/21
Parra-Medina R, Herrera S, Jaime M, et al. | Acta Haematol
Aim: To review cases in the literature about COVID-19 autopsies that reported microthrombi in different organs.
CLINICAL CHARACTERISTICS
4/20/21
Long J, Luo Y, Wei Y, et al. | Am J Emerg Med
Aim: To evaluate the mortality risks associated with CVD and cardiac injury among hospitalized COVID-19 patients, especially in subgroups of populations in different countries.
CLINICAL CHARACTERISTICS
4/17/21
Sing A, Hussain S, Antony B | Diabetes Metab Syndr
Aim: To systematically review the evidence on clinical outcomes in NAFLD patients with COVID-19.
CLINICAL CHARACTERISTICS
4/16/21
Akbar MR, Wibowo A, Pranata R, et al. | Front Nutr
Aim: To assess whether low serum 25-hydroxyvitamin D (25-OHD) level is associated with susceptibility to COVID-19, severity, and mortality related to COVID-19.
CLINICAL CHARACTERISTICS
4/16/21
Zuin M, Rigatelli G, Bilato C, et al. | J Interv Card Electrophysiol
Aim: To investigate the pooled prevalence of pre-existing AF and its short-term mortality risk in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/15/21
Kashetsky N, Mukovozov IM, Bergman J. | J Cutan Med Surg
Aim: To summarize reports of CLL coinciding with SARS-CoV-2 infection to clarify the prevalence, clinical relevance, and prognostic value of these lesions.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in ESRD patients with hemodialysis, peritoneal dialysis, and kidney transplantation.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Pongpirul W, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in ESRD patients with hemodialysis.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Eiamsitrakoon T, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in PD patients.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in KT patients.
CLINICAL CHARACTERISTICS
4/14/21
Qi K, Zeng W, Ye M, et al. | Medicine
Aim: To describe the clinical, laboratory, and imaging characteristics of children with COVID-19 based on published data of pediatric COVID-19 cases.
CLINICAL CHARACTERISTICS
4/14/21
Mondal R, Deb S, Shome G, et al. | Mult Scler Relat Disord
Aim: To summarize so far available pieces of evidence documenting de novo novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) mediated spinal cord demyelinating diseases.
UPDATED
CLINICAL CHARACTERISTICS
4/14/21
Flook M, Jackson C, Vasileiou E, et al. | BMC Infect Dis
Aim: To review the evidence on the risk factors for severity, disease, and mortality for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Katoto PDMC, Brand AS, Bakan B, et al. | Environ Health
Aim: To review the evidence on whether exposure to acute and chronic air pollution influences the COVID-19 epidemiologic curve.
CLINICAL CHARACTERISTICS
4/13/21
Yao MQ, Zheng QX, Xu J, et al. | Zhejiang Univ Sci B
Aim: To summarize the demographical, clinical, and laboratorial characteristics of non-recurrence and recurrence groups.
CLINICAL CHARACTERISTICS
4/13/21
Handayani DR, Juliastuti H, Nawangsih EN, et al. | Obes Med
Aim: To assess the prognostic value of fasting hyperglycemia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Pranata R, Huang I, Lawrensia S, et al. | Pharmacol Rep
Aim: To address the current interest of whether the administration of PPI could increase the susceptibility and risk of poor outcome in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Hariyanto TI, Kurniawan A | Nutr Metab Cardiovasc Dis
Aim: To analyze the association between statin use and composite poor outcomes of COVID-19.
CLINICAL CHARACTERISTICS
4/13/21
Trimboli P, Camponovo C, Scappaticcio L, et al. | Rev Endocr Metab Disord
Aim: To review the evidence on thyroid dysfunction in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/12/21